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ABSTRACT 
Julia Louise Malik Dunn: Modulating Innate Immunity Improves Outcomes in Acute Lung 
Injury 
(Under the Direction of Bruce A. Cairns) 
 
Pulmonary inflammation following traumatic injury disrupts the lung architecture, leading to 
impaired oxygen exchange and rendering patients susceptible to life threatening bacterial 
infections.  Innate immunity is central to the resolution of infection; however, excessive immune 
responses cause unresolved inflammation that exacerbate tissue damage.  We hypothesize that 
partially attenuating recruitment of innate immune cells without impairing their function in situ 
will improve outcomes for patients diagnosed with acute lung injury (ALI) following burns and 
smoke inhalation by restoring homeostasis. Using mouse models of injury, we characterized the 
innate immune response in the lung following burns and smoke inhalation to establish 
mechanistic relationships that drive inflammation and to test therapeutic interventions.  We show 
that significant neutrophil recruitment to the lung following burn injury is driven by damage 
associated molecular patterns (DAMPs); however, this recruitment does not result in improved 
bacterial clearance following pulmonary infection. To explore the factors that drive inflammation 
in a clinically relevant direct lung injury model, we developed and validated a novel murine 
model of acute smoke inhalation.  This model mimics granulocyte recruitment, anti-
inflammatory cytokine profile, DAMP release, and susceptibility to bacterial infection that are 
important drivers of outcome in patients.  Using this model, we differentiate between correlative 
and causative inflammatory relationships in ALI.  First, we demonstrate that inducible nitric 
 iv 
oxide synthase is required for upregulation of interleukin-10 (IL-10), monocyte chemotactic 
protein 1, and hyaluronic acid (HA) following inhalational injury, but not for bacterial clearance.  
Thus, we propose that the relationship between elevated IL-10 and the onset of bacterial 
infection in patients may be correlative rather than causative.  Furthermore, we demonstrate that 
neutrophil recruitment is driven by the chemokine CXCL1 as well as leukotriene B4, and we 
present data that granulocyte NADPH oxidase (NOX2) rapidly eliminates these signals and 
prevents excessive inflammation.  Finally, we demonstrate that a 50% decrease in early 
neutrophil recruitment to the lung after smoke inhalation leads to decreased tissue damage and 
improved outcomes following bacterial challenge.  Collectively, these data demonstrate the 
clinical relevance of our experimental model and suggest that downstream targets of NOX2 
activity are promising candidates for accelerating resolution of inflammation in patients.  
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CHAPTER 1: INNATE IMMUNITY IS CRITICAL FOR SURVIVAL FOLLOWING 
TRAUMA 
Introduction  
Traumatic injury is the leading cause of death in Americans under 44 years of age, and poses a 
threat to human health that will never be eliminated as long as people continue to drive cars, live inside 
flammable1 structures, or go to war.  Recovery from traumatic injury requires the body to accomplish two 
objectives: first, to combat the threat of infection that results from damage to normal physiological 
barriers, and second, to replace injured tissue with new, healthy tissue.  Both processes are orchestrated 
by the immune system and in most cases they occur sequentially.  In the early stages of inflammation, 
immune cells are recruited to damaged tissue and infectious threats are neutralized.  Resolution can then 
occur, during which phase the immune system clears dead or damaged cells and debris, promotes 
proliferation of local stromal cells, and restructures the extracellular matrix.  Failure to initiate the initial 
inflammatory response can lead to infectious complications.  Failure to progress to the resolution phase 
leads to scar tissue, fibrosis, and may increase the extent of tissue damage.  Immune activity that causes 
tissue damage or interferes with organ function is referred to as immunopathology, which can be 
associated with a hyperactive inflammatory phase or persistent inflammation that fails to resolve.   A 
well-orchestrated innate immune response is a critical determinant of patient outcomes following 
traumatic injury, and presents a constellation of potential therapeutic targets.   
Our central hypothesis is that some aspects of the innate immune response following trauma are 
beneficial and assist in efficient progress from the inflammatory to the resolution phase during recovery, 
                                                           
1 Despite popularity of ‘flame retardant’ materials, especially textiles, evidence suggests that in a structural fire these 
materials inevitably catch fire.  Additionally, the compounds that they contain to make them ‘flame retardant’ are 
toxic.  
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while aberrant responses either fail to clear infection or interfere with resolution.  Our objective is to 
identify opportunities for intervention by examining the relationship between inflammation and outcomes 
in patients and animal models of injury.  This study outlines research aimed at understanding how the 
lung is impacted by burn and inhalational injuries, and how immune activity can be modulated to promote 
successful transition from inflammation to resolution.  
Inflammation drives outcome in trauma patients. 
For many years it was thought that traumatic injury resulted in a biphasic inflammatory response 
that has been extensively characterized following sepsis.  This paradigm suggests an initial systemic 
inflammatory response syndrome (SIRS) marked by pro-inflammatory cytokines and a hyperactive 
immune state.  The SIRS phase was thought to be followed by a compensatory anti-inflammatory 
response syndrome (CARS), in which the anti-inflammatory cytokine profile limits tissue damage due to 
immunopathology.  Novel methodologies of the ‘-omics’ age have enabled a more nuanced analysis, 
which suggests that pro- and anti-inflammatory genes are expressed simultaneously after trauma (1-6).  
Traumatic injury causes differential expression of >80% of genes in the human genome within 28 
days (1). Remarkably, the type of injury (i.e. blunt trauma vs. burn) is of only marginal importance to the 
genetic changes that occur, indicating that the physiological responses to these injuries are more alike 
than they are different.  Despite the presence of anti-inflammatory cytokines during the early phase and 
pro-inflammatory cytokines during the late phase, which contradict the straightforward SIRS/CARS 
paradigm, it remains true that patients are at the greatest risk of developing organ failure secondary to 
shock early after injury and of succumbing to fatal opportunistic infections late after injury (4, 7, 8).  
Changes in serum levels of cytokines, chemokines, and immunogenic growth factors persist for 
years after burn injury, especially in pediatric patients (9). Because of the prolonged inflammatory and 
hypermetabolic state that follows burn injury, patients experience many physiological problems 
associated with persistent inflammation, including metabolic dysregulation and cardiovascular stress (9-
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11).  Interference with aberrant inflammatory processes after trauma is therefore likely to improve long-
term prognosis for trauma patients by promoting a prompt and complete return to homeostasis.  
Excessive inflammation leads to organ dysfunction.  Damaged tissue and the tissue-resident 
immune cells release a battery of signals into circulation that impact tissues beyond the initial damage 
site.  Increased systemic circulation of damage-associated molecular patterns (DAMPs) as well as 
cytokines, chemokines and growth factors in serum have been observed following burn injury in both 
humans and animal models (12-15).  Inflammatory signals from the burn wound exit the site of damage 
through venous circulation and cause inflammation in secondary organs, with the heart and lungs being 
chief collateral targets because they receive the greatest concentration of inflammatory factors in the 
blood (16, 17).  
Presence of a burn wound increases sensitivity to inflammatory and infectious signals such as 
C5a and LPS, and this sensitivity disrupts normal organ function by promoting edema and congestion of 
microvasculature.  Attenuating inflammation after trauma in animal models by depleting complement or 
neutrophils either prior to or shortly after burn injury significantly reduces –or eliminates entirely –the 
collateral damage to distal organs (18, 19).  These results have failed to translate to the clinic because they 
do not account for the opportunistic infections that would swamp patients if their innate immune 
functions were so completely abolished.  They do, however, illustrate the power of immune modulation in 
alleviating organ dysfunction after injury.  
Aberrant inflammatory response leads to infectious complications. Anti-inflammatory signals 
present in patient biofluids, specifically serum and broncho-alveolar lavage fluid (BALF), are predictive 
of outcomes in patients diagnosed with burns and inhalational injury (3, 12, 20).  Interleukin 10 (IL-10) is 
a hallmark anti-inflammatory cytokine and its elevation in patients with inhalational injury predicts the 
onset of infection (20).  In a murine model of burn injury, an abundance of innate immune cells 
expressing IL-10 was associated with failure to control bacterial growth following a skin infection (21). 
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Moreover, administration of flagellin stimulated innate immune activation through toll-like receptor 
(TLR) ligation, reversed the anti-inflammatory immune polarization following burn injury, and improved 
bacterial clearance (21).  These data illustrate two points.  First, that despite immune hyperactivity 
sufficient to cause organ damage, the immune system struggles to clear even minimally invasive 
pathogens such as Pseudomonas aeruginosa.  Second, that it is possible to modulate the immune response 
to improve detection and clearance of certain pathogens.  
The lung is a key site of immunopathology and infection that hinders patient outcomes.  
In the latter half of the 20th century significant gains were made in improving survival and 
prognosis in burn patients through improved wound excision and grafting strategies and resuscitation 
techniques (22, 23).  Whereas burn wound infections had long been the main challenge to patient 
recovery, this clinical threat has been overtaken by bacterial pneumonia, which today accounts for the 
majority of burn unit fatalities (8). 
The lung presents a two-fold challenge after trauma (24, 25).  First, immune infiltration disrupts 
gas exchange and can lead to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) (26).  
Second, despite significant immune cell recruitment, immunological surveillance fails to control bacteria 
and patients often develop life-threatening bacterial pneumonia (8). The leading cause of pneumonia in 
burn patients is P. aeruginosa, which is an opportunistic bacterium that is rapidly cleared by neutrophils 
in healthy individuals (8, 27).  
ALI follows trauma.  ALI is defined in humans as the presence of bilateral infiltrates to the lung 
tissue and impaired oxygen exchange (25, 28).  Progressively more severe impairment in oxygen 
exchange marks a transition from ALI to ARDS (28). ALI/ARDS can be brought on by a spectrum of 
stimuli including infection and damage, which affect the lung either directly or indirectly (Table 1.1).  
The cellular and molecular characteristics of ALI are similarly variable, though they all involve disruption 
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of the alveolar/capillary barrier and damage to the airway epithelium either in the alveoli or in larger 
airways.  
Mouse models of ALI mirror the complexity and non-uniformity of the human disease, 
comprising a full spectrum of stimuli and resulting in a wide array of outcomes (29-31).  Measurement of 
ALI is somewhat different in mice compared to humans in large part because few laboratories have access 
to the equipment required to measure oxygen saturation in the blood or to observe lung infiltrates in real-
time (29).  Small animal models of ALI are therefore defined by the extent to which they fulfill each of 
four broadly defined categories: perturbation of the alveolar/capillary barrier, evidence of an 
inflammatory response, histological evidence of tissue damage, and disrupted lung function.  
A direct pulmonary insult is not required for progression to ALI. Inflammatory signals from an 
injury that are released into the blood invariably make their way via venous circulation to the heart before 
being pumped into pulmonary circulation. The lung is therefore a target for organ damage subsequent to 
injury because it receives 100% of cardiac output, therefore it sees more highly concentrated 
inflammatory mediators than other organs such as the liver or kidney.  C5a release after burn injury 
causes an increase in vascular ICAM-1 expression in pulmonary microvasculature (19), which causes 
neutrophil accumulation in the capillaries and contributes to vascular permeability (18).  Inhibiting 
complement activation or depleting complement factors prevented sequestration of neutrophils in 
pulmonary microvasculature after burn injury, however because sequestration occurs within minutes of 
the injury it is only possible to inhibit it through prophylactic treatment, which is impractical for the 
treatment of burn injuries outside of the laboratory (18, 19).  
Neutrophils accumulating in the pulmonary microvasculature cause damage to the endothelial-
capillary barrier that can be prevented by administration of catalase or superoxide dismutase, which 
inhibit reactive oxygen species activity (18).  Damage to the endothelium results in leakage of serum 
proteins and fluid from the vasculature, causing either thickening of the interstitium, fluid buildup in the 
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alveoli, or both.  In summary, release of inflammatory mediators from damaged tissue precipitates 
complement activation, resulting in changes to the pulmonary microvasculature and accumulation of 
activated neutrophils that degranulate and cause tissue damage that culminates in ALI. 
Immune function in the lung is altered by injury.  
Inhalational injury presents a significant clinical challenge. Inhalational injury is a common 
comorbidity observed in burn patients.  The impact of inhalational injury on the outcome of trauma is 
significant, as it increases mortality and, in survivors, leads to a three-fold increase in the duration of 
hospitalization and a substantial increase in healthcare costs (32).  Despite its frequency, inhalational 
injury is not a straightforward diagnosis because disease presentation depends on the smoke source, 
which varies from structure to structure, as well as concentration and duration of exposure (20, 33, 34).  
Additionally, the rate and severity of inhalational injuries are increasing as structures transition to 
synthetic building materials, because many synthetics burn faster and release more airborne toxics than 
wood or stone structures (24).  
Due to the significant cost of treating inhalational injuries without targeted therapies, it is 
imperative that ongoing research attempt to address this patient population. Optimal immune function in 
the lung plays a pivotal role in the two primary challenges that face patients, specifically combatting 
infection and healing damaged tissue. We therefore propose that it is imperative to characterize the 
immune response in the lung following injury, specifically burns and inhalational injury, and to explore 
treatments to modulate that response.  
Significant work has been done to characterize and quantify the immune response in the lung in 
different models of ALI including pulmonary infection, sepsis, and ventilator-associated (mechanical) 
lung injuries (29, 31, 35-45). Although these injuries differ significantly from acute smoke inhalation, it is 
instructive to consider the results of those studies in order to outline themes and patterns as well as to 
identify points of comparison between patients and animal models.  Here we discuss the state of the 
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literature surrounding immune function in various models of ALI, and have divided the analysis into six 
categories: transcription factors, proteases, reactive oxygen and nitrogen species (RONS), toll-like 
receptors, cytokines, and chemokines.  
Transcription factors. Nuclear Factor (NF)-B signaling in both epithelial cells and myeloid cells 
in the lung play a significant role in the etiology of ALI.  Introduction of a viral vector to promote 
expression of IB attenuated NFB signaling in epithelial cells in a lipopolysaccharide (LPS) model of 
ALI (35).  This attenuated neutrophil recruitment resulted in decreased IL-6 expression and protein 
leakage in the BALF (35).  Additionally, low concentrations of nitric oxide (NO) promote NFB 
activation, which promotes iNOS expression to generate a positive feedback loop that increases pro-
inflammatory cytokine and chemokine production (46).  
PPAR is required for the maturation of anti-inflammatory “alternately” activated macrophages, 
which drive resolution and tissue repair (47).  In a mouse model of asthma, agonists of peroxisome 
proliferator-activated receptor (PPAR)- and - attenuated inflammation by reducing the recruitment of 
neutrophils and eosinophils to the airway (48).   
Proteases. Matrix metalloproteinase 8 (MMP8), also referred to as neutrophil collagenase, is an 
enzyme released by activated neutrophils upon extravasation from the vasculature to render the 
extracellular matrix more permissive to cellular migration and tissue remodeling.  MMP8 is upregulated 
in peripheral leukocytes from trauma patients within 12h of injury (1).  Furthermore, MMP8-deficient 
mice were partially protected from injury in a ventilator-induced lung injury (VILI) model, and MMP8 
inhibitors exhibited a similar protective effect in VILI and a burn-blast injury (31, 49, 50).  
MMP9, also known as Gelatinase B, is produced as neutrophils differentiate and mature in the 
bone marrow and is stored in granules.  When neutrophils degranulate, MMP9 is released and acts on the 
extracellular matrix as well as on chemokines, such as IL-8, and cytokines, such as IL-1, to increase 
their activity and binding affinity (51).  The feed-forward mechanism, wherein MMP9 activity promotes 
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IL-8 potency, which promotes neutrophil recruitment/degranulation and therefore MMP9 activity, results 
in compounded inflammation.  The ability of MMP9 to promote runaway inflammation may be why 
MMP9 deficiency was found to be protective against septic shock in an endotoxemia model (51). 
Reactive oxygen and nitrogen species. Reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) are highly reactive small molecules that serve a variety of effector functions.  Under 
physiological conditions, reactive oxygen and nitrogen species (RONS) are potent signaling molecules 
that can act in an autocrine or paracrine manner and are especially important in regulating vascular tone to 
promote healthy blood pressure.  When activated, phagocytic cells pump ROS into phagosomes in order 
to degrade microbial pathogens and scavenged debris (52).  ROS are potent antimicrobial effector 
molecules that can cause unwanted tissue damage when they are produced in excess, as is the case in the 
lung following injury (18, 36, 37). ROS and RNS react with one another to generate peroxynitrite, which 
is an especially potent oxidizing agent (53).  
ROS in the lung after injury can be produced by multiple processes. In addition to xanthine 
oxidase, which becomes activated following damage to the airway epithelium and produces ROS, 
infiltrating phagocytes express NADPH oxidase 2 (NOX2), a potent source of both intra- and 
extracellular ROS (19, 52).  NOX2 exists as an inactive complex in the plasma membrane that becomes 
part of the phagosome when the membrane folds during phagocytosis (52).  Upon activation, the NOX2 
machinery fully assembles on the cytoplasmic side of the membrane and results in an electron transport 
chain that generates ROS inside the phagosome (52).  In some activated cells, the NOX2 machinery 
assembles at the cytoplasmic membrane, resulting in generation of extracellular ROS (52). 
Neutrophil accumulation and activation are associated with oxidative tissue damage in an ovine 
model of cotton smoke inhalation and bacterial infection (36). Superoxide dismutase (SOD), which 
converts superoxide into hydrogen peroxide, is increased in the macrophage proteome of humans with 
ARDS in the early phase after diagnosis compared to resolution phase, suggesting an attempt by local 
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cells to cope with the elevated burden of ROS (2).  The relative success of antioxidants derived from 
Vitamin E, most notably γ-tocopherol, in attenuating ALI after smoke inhalation further implicates ROS 
in immunopathology (24). Similarly, administration of a peroxynitrite scavenger in a mouse model of 
cotton smoke inhalation with burn injury inhibited protein oxidation and resulted in a concomitant 
increase in IL-10 production as well as decreased damage to lung architecture (37).  Extracellular ROS 
leads to oxidation of proteins and lipids, which can alter or abrogate their function and may render them 
immunostimulatory.  Oxidized lipids are detected by TLR4 to promote inflammation (38).   
There are several established mechanisms by which ROS production promotes resolution of 
inflammation by decreaseing neutrophil recruitment, promoting neutrophil apoptosis, and increasing 
efferocytosis.  Leukotriene B4 (LTB4), a small molecule with potent activity as a neutrophil 
chemoattractant, is inactivated in the presence of ROS, potentially reflective of a self-limiting immune 
mechanism (54). NOX2-dependent ROS production in neutrophils is critical for upregulation of modified 
phosphatidyl serine (Lyso-PS) on the cell surface, which leads to clearance of local neutrophils (55).  In a 
model of peritonitis using mice lacking the main transmembrane subunit of the NOX2 machinery, 
gp91phox, local neutrophils were not cleared and recruitment continued, resulting in sustained 
inflammation (55).  
The role of neutrophil derived ROS in limiting inflammation has been similarly suggested by a 
murine model of experimental colitis, which is marked by recruitment of activated neutrophils (56).  In 
this model, depletion of local oxygen by neutrophils generating ROS resulted in stabilization of hypoxia-
inducible factor 1 (HIF1) in stromal cells, which promoted resolution of inflammation and a return to 
tissue homeostasis.  This mechanism was disrupted when colitis was induced in mice deficient for NOX2 
activity, leading to increased tissue damage that was partially reversible through pharmacological 
stabilization of HIF1 (56).  In summary, ROS are potent antimicrobial molecules that can cause 
immunopathology via tissue oxidation when released in excess, however a growing body of evidence 
suggests that ablation of ROS production inhibits resolution of inflammation.  
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A hallmark RNS nitric oxide (NO) is a key regulator of vascular dynamics and, though 
interactions with the vascular endothelium, inflammation.  NO is produced by nitric oxide synthases 
(NOS) of which there are three known isoforms: endogenous (eNOS), inducible (iNOS), and neuronal 
(nNOS).  iNOS is expressed by activated leukocytes, especially myeloid cells and granulocytes, and NO 
derived from iNOS is associated with changes in cytokine and chemokine production and signaling as 
well as leukocyte migration and apoptosis (46, 53, 57-59).  NO regulates iNOS expression, promotes 
leukocyte adhesion to –and rolling on –the vascular endithelium, modulates chemokine production 
(including MCP1 and MIP2) and activity (IL-8), and promotes neutrophil degranulation and ROS 
production (46, 53).  In certain cell types high concentrations of NO promote apoptosis; however, NO 
differentially impacts macrophage survival and function to allow macrophages to persist during 
inflammation, when NO concentrations are elevated, and to apoptose during resolution when NO 
concentrations abate (59). NO has been used as a highly sensitive real time biomarker of inflammation 
and immune competence, and can be measured directly in exhaled gases or blood (30, 60).  
The signals that induce iNOS expression and activity are incompletely understood, in part 
because the impact of certain stimuli appears to depend largely on concentration. Under resting 
conditions, epithelial cells and alveolar macrophages express Arg2, which counteracts iNOS expression 
and activity; however, iNOS is expressed in these cell types following sepsis (61). Upregulation of iNOS 
expression and production of NO are hallmarks of acute lung injury in a variety of models, including 
smoke inhalation (40, 57, 61, 62).  Increased iNOS expression and activity in the airway were observed in 
a mouse model of cotton smoke inhalation with and without burn injury (40).  Moreover, NO derived 
from iNOS contributed to cardiac dysfunction following smoke inhalation and burn injury in sheep (41). 
Toll-like receptors. Toll-like receptors (TLR) recognize conserved molecular patterns associated 
with bacterial or viral structures and are the first line of defense for detecting infection.  TLR4 is 
responsible for detecting LPS and is also known to respond to DAMPs including oxidized lipids and 
hyaluronic acid (HA) (38, 63, 64). Signaling via TLR4 presents a double-edged sword in the onset and 
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resolution of ALI.  On one hand, detection of oxidized lipids and signaling via TLR-TRIF-NFkB in 
myeloid cells promotes ALI in an acid aspiration model (38).  On the other hand, deficient TLR signaling 
adversely effects survival in a Pseudomonas-induced model of ALI (42).  
Changes in expression of TLR and sensitivity to TLR ligation on immune cells following burn 
injury have been described previously in both humans and mice (1, 21, 65, 66).  Administration of 
flagellin, a TLR5 ligand, following burn injury improved clearance of P. aeruginosa in mice (21, 67).  In 
another study neutrophil recruitment to the lung after bacterial challenge was positively correlated with 
bacterial clearance and survival, in connection with TLR4 signaling (42). 
Cytokine production and secretion. Interleukin (IL)-6 has been extensively described for its role 
in the acute pro-inflammatory response following burn and inhalational injury (38, 68-70).  IL-6 
concentration is tightly correlated with tissue damage, persistent inflammation, and the onset of fibrosis 
(71).  Most evidence suggests that IL-6 may be more relevant in burn and combined injuries as opposed 
to inhalational injuries, alone.  IL-6 signaling is upregulated in trauma patients (1), however it was not 
found to be elevated in BALF from patients with inhalational injury, alone (4).  More sensitive methods 
do point to some role of IL-6 in pulmonary inflammation.  Patient BAL-derived leukocytes produced IL-6 
following ex vivo LPS stimulation (4), and IL-6 mRNA was detected in lung tissue within 24 h of injury 
and infection in an ovine model of cotton smoke exposure (45).  
A hallmark anti-inflammatory cytokine, IL-10, has been correlated with outcomes in multiple 
studies of patients with inhalational injury.  Like TLR4 expression and signaling, IL-10 is prominent as 
having conflicting roles in ALI, as it has been shown to suppress antimicrobial responses but may also 
help prevent immunopathology.  Our group examined BALF from patients diagnosed with inhalational 
injury and identified elevated IL-10 in patients with compromised lung function who were at risk of 
developing pneumonia (20).  Others have observed elevated IL-10 in non-survivors compared to 
survivors (4). In a model of LPS-induced lung injury, a tolerizing dose of LPS was found to be 
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efficacious in reducing tissue damage due to IL-10 production by macrophages upon subsequent 
challenge (43). IL-10+IL-12- neutrophils that appear following burn injury have been implicated in 
susceptibility to infection, however they can be eliminated by treatment with a TLR ligand, leading to 
improved response to bacterial challenge (21).  
Chemokine production and secretion. IL-8, also known as CXCL8 in humans, is a chemokine 
produced by granylocytes and epithelial cells that acts on neutrophils and other granulocytes to promote 
migration and phagocytosis.  IL-8 is elevated in burn patients, even more in severe burns than mild 
injuries (72).  Furthermore, while levels of IL-8 dropped off following injury without infectious 
complications, sepsis resulted in a second peak in IL-8 (73).  IL-8 was elevated in patients diagnosed with 
inhalational injury, with higher concentrations observed in survivors compared to non-survivors (4).   
Mice have two homologues of IL-8; CXCL1, also known as KC, and CXCL2, also known as 
macrophage inhibitory protein 2 (MIP2).  In an animal model, inhibition of CXCL1 secretion into the 
serum following burn led to a decrease in several markers of lung injury (74).  It has been shown that 
diesel exhaust particles exacerbate asthma symptoms in mice by upregulating expression of CXCL1 and 
CXCL2, and that inhibition of these signals suppressed pulmonary inflammation and improved outcomes 
(75).  Both CXCL1 and CXCL2 are recognized by CXCR2, and blockade of either the ligands or receptor 
significantly attenuated pulmonary damage in a murine model of ventilator-induced lung injury (VILI) 
(44). Moreover, CXCR2 agonists have been found to be relevant in several models of direct lung injury 
including acid aspiration, VILI, and LPS instillation (31).    
Expression of CCL2, also known as monocyte chemoattractant protein 1 (MCP1), is elevated early 
following thermal injuries and is associated with recruitment of pro-inflammatory “classically activated” 
macrophages to the site of injury and the acute hyper-inflammatory response that can precipitate shock in 
patients (47, 76, 77).  Examination of BALF from patients diagnosed with inhalational injury indicated 
that MCP-1 was elevated but not to an extent that achieved statistical significance (4).  Finally, ubiquitin 
 13 
and stromal-derived factor (SDF)1α, which are elevated in patient BALF, are agonists of CXCR4 and are 
thought to have a protective, anti-inflammatory effect (78).  
Optimized innate immune function would improve patient outcomes.  
Correct resolution of inflammation requires the coordination of tissue resident macrophages and 
recruited immune cells.  Neutrophils are typically the first cells recruited, and once activated they 
phagocytose bacteria, release neutrophil extracellular traps to kill extracellular pathogens, and modulate 
the response of other immune cells.   Macrophage numbers do not change between the acute 
(inflammatory) phase and resolution of ARDS, while a significant decrease is observed in neutrophil 
numbers (2).  During resolution, neutrophils initiate apoptosis and signal to macrophages to phagocytose 
and degrade the dying cells through a process known as efferocytosis.  Clearance of apoptotic neutrophils 
causes macrophages to adopt an anti-inflammatory phenotype to suppress further immune cell recruitment 
and repair local tissue that may have been damaged by the initial insult, ensuing infection, 
immunopathology, or any combination thereof.  
In modulating the immune response to promote resolution without impairing antimicrobial 
function, it is important to visualize a return to homeostasis rather than “skewing” towards either a pro- or 
anti-inflammatory response.  Suppressing immunopathology will not benefit patients if it renders them 
immunologically paralyzed so that they succumb to infection.  Conversely, prompting phagocytes to clear 
bacteria and debris must be achieved without causing collateral damage and thereby creating more debris, 
potentially leading to lung failure.  
Experimental Approach to Study Lung Injury in Mice 
There is substantial criticism of mouse models for their imperfection in mimicking human 
disease, however they remain the most effective tool for achieving mechanistic insight into complex 
disease processes and developing therapeutic interventions.  Despite differences in magnitude, innate 
immune responses to stress in mice and humans are largely similar, including cytokine and chemokine 
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production, leukocyte circulation and activation (79). Nevertheless, model selection and design must be 
approached with care to ensure that results of mouse studies are translationally relevant.  Existing studies 
of acute lung injury, particularly subsequent to smoke inhalation, exhibit disagreement between clinical 
data and animal data (24).  The majority of research into acute inhalational injury has relied on cotton 
smoke inhalation in either rats, mice, or sheep (36, 37, 40, 41, 45, 80, 81). It has been shown, however, 
that there are differences between injury induced by cotton smoke, wood smoke, and plastic smoke (81). 
Because the majority of acute inhalational injuries that result in hospitalization do not result from the 
combustion of pure cotton toweling, as is used in the above animal studies, we propose that a novel model 
is needed to study inhalational injury.  
There is a diverse and extensive array of animal models of ALI –for this reason the American 
Thoracic Society produced a document outlining standards, characteristics, and measurements that should 
be present in any model (29). We used these guidelines to design an appropriate animal model and to 
define parameters that would be used to determine success of any therapeutic intervention.   
We started by approaching the impact of systemic inflammation subsequent to cutaneous burn 
injury on the immunological environment of the lung.  Because infections after burn injury pose the 
greatest clinical threat late after injury, we conducted initial studies two weeks after burn injury.  Chapter 
2 describes how systemic immune dysfunction following burn injury correlates with bacterial clearance in 
the lung.  In chapter 3 we investigated metabolic control of innate immunity in the lung and identified a 
distinction between neutrophil recruitment and neutrophil RONS production in bacterial clearance.  These 
studies highlight changes in innate immune function after burn injury that impact immunological 
surveillance in the lung.  
In order to explore factors that lead to long-term immune dysfunction in the lung after injury, we 
studied acute responses in order to gain insight into the chain of events that results in failure to resolve 
inflammation.  Our objective was to compare ALI that develops in patients with severe injuries but no 
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direct lung insult with ALI that develops following inhalational injury.  We therefore chose to utilize both 
direct and an indirect injury models in mice.  In chapter 4 we describe the impact of systemic damage on 
pulmonary inflammation by measuring the ability of intravenous DAMPs to induce ALI.  We show that 
damage from a 20% total body surface area (TBSA) burn, alone, did not induce ALI, but supplementation 
with exogenous DAMPs promoted leakage of serum proteins and recruitment of neutrophils to the 
airway.  Observation of these phenotypes without either a pathogenic signal or a direct insult to the lung 
is a novel finding and represents a meaningful step in the study of ALI in trauma patients who are not 
diagnosed with inhalational injury. 
To study the consequences of a direct pulmonary challenge, specifically inhalational injury, we 
developed and characterized a novel model of wood smoke inhalation.  In chapter 5 we identified early 
neutrophilia as a source of tissue damage that leads to susceptibility to systemic bacterial challenge and 
showed that partial inhibition of neutrophil chemotaxis can reduce damage without adversely impacting 
bacterial clearance.  Finally, the results outlined in chapter 6 address granulocyte function by quantifying 
neutrophil RONS production and characterizing the response to inhalational injury in mice deficient for 
NOX2.  The results of these studies highlight the importance of the novel model of smoke inhalation, 
which reproduces many key characteristics of patients diagnosed with inhalational injury, represents an 
opportunity to develop therapeutic interventions, and adds meaningfully to existing literature on murine 
models of ALI.  
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TABLES 
Table 1.1: Challenges that lead to Acute Lung Injury (ALI).  
 Pathogen Signal Damage Signal 
Systemic Sepsis 
Severe Burn Injury 
Blunt Force Trauma 
Pulmonary 
Influenza 
Pneumonia 
Acid Aspiration 
Inhalational Injury 
Ventilator-Induced Lung Injury 
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CHAPTER 2: DIRECT DETECTION OF BLOOD NITRIC OXIDE REVEALS A BURN-
DEPENDENT DECREASE OF NITRIC OXIDE IN RESPONSE TO PSEUDOMONAS 
AERUGINOSA INFECTION12 
Summary 
Purpose: Burn injury is associated with severe immune dysfunction, including an anti-
inflammatory state that occurs late after burn injury. While increased nitric oxide (NO) production is 
associated with severe infection and sepsis, the effect of burn trauma on these levels during a non-lethal 
infection remains unknown. We hypothesized that in a mouse model, 1) NO levels would be increased 
after nonlethal infection without trauma and 2) burn injury would lead to decreased NO production even 
during infection. Methods: Mice were infected via intra-tracheal inoculation with Pseudomonas 
aeruginosa 14 d following a 20% total body surface area contact burn. At 48 h following infection, blood 
was drawn to quantify NO concentrations using a microfluidic electrochemical sensor. Significant 
findings: In uninjured mice, infection caused a significant increase in blood NO levels. Increases in NO 
occurred in a dose-dependent response to the bacterial inoculum. Following burn injury, an identical 
infection did not elicit increases in NO. Conclusions: While increases in NO are expected over the course 
of an infection without prior trauma, burn injury and subsequent immune suppression decreases NO 
levels even in the presence of infection. 
                                                           
1 Adapted for this dissertation from Dunn JLM, Hunter RA, Gast K, Maile R, Cairns BA, and Schoenfish MH.  
Direct detection of blood nitric oxide reveals a burn-dependent decrease of nitric oxide in response to Pseudomonas 
aeruginosa infection.  2016. Burns 42(7):1522-1527.  
2 Attribution: Julia Dunn performed all of the experiments including mouse injury and infection as well as collection 
of blood and tissue.  Rebecca Hunter conducted measurement and analysis of NO in blood. Julia Dunn and Rebecca 
Hunter co-first authored the manuscript. Karli Gast assisted in tissue collections.  
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Introduction 
Physical trauma such as burn injury causes severe immune dysfunction, often resulting in 
infection, sepsis, multiple organ dysfunction, and death (1). Historically, this immune response has been 
characterized by an initial pro-inflammatory period and a subsequent anti-inflammatory phase (1, 2). 
These periods have been referred to as the systemic inflammatory response syndrome (SIRS), during 
which pro-inflammatory mediators (e.g., tumor necrosis factor, interleukin-6, interleukin-1) are released, 
and a compensatory anti-inflammatory response syndrome (CARS) thought to limit damage due to 
chronic inflammation (1-6). More recent studies have illustrated a more complex scenario, wherein pro- 
and anti-inflammatory cytokines may be secreted simultaneously, suggesting that the SIRS/CARS 
paradigm may be insufficient to characterize the immune response to trauma (3-5). Despite this paradigm 
shift, it remains true that late after trauma patients exhibit elevated susceptibility to nosocomial infection 
(6-8). Burn patients are especially prone to ventilator-associated pneumonia and wound infections (6, 9), 
and the leading cause of death following burn injury is related to infection and sepsis (6, 10). In 
particular, pulmonary infections by Gram-negative Pseudomonas aeruginosa are quite common (7). 
Novel methods are needed that will enable healthcare providers and researchers to monitor the immune 
response in real-time during trauma and infection.  
 Nitric oxide (NO) is a free radical species that is intricately involved with the innate immune 
response (11-26), and as such, in vivo levels will likely reflect the immune status of an individual. Indeed, 
the up-regulation of inducible nitric oxide synthase (iNOS) early after trauma has been observed, in 
addition to accumulation of NO byproducts in blood and tissue (7, 12, 17, 27-31). Until recently, direct 
detection of NO in whole blood was not feasible, requiring either the measurement of its byproducts (i.e., 
nitrate and nitrate) or the use of complex instrumentation (i.e., electron paramagnetic resonance 
spectroscopy) (32). Studies measuring NO byproducts in sheep have found that serum NO is increased in 
sheep after burn and smoke inhalation, and that this increase can be blocked with iNOS inhibitors (33).  
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Direct measurement of NO is likely to rapidly and sensitively detect changes in patient status; 
therefore, such measurements should be incorporated into clinically relevant models.  Because of the 
availability of genetically modified mice, confirming the usefulness of NO as a readout in mouse models 
of trauma will enable elucidation of disease mechanisms that impact NO production. Recently, a 
microfluidic amperometric sensor was developed and used to directly measure increases in NO levels 
during a lethal murine model of sepsis (28).  
We expect that NO levels may be decreased during an infection following burn injury. Because 
patients demonstrate susceptibility to infection late after trauma, we focused on NO levels in a nonlethal 
infection model at 14 days after burn injury. Quantifying changes in NO concentration may allow for the 
elucidation of immune dysfunction, indicated by either elevated levels during systemic infection or 
decreased levels during immune suppression. 
Methods 
Murine model of burn injury and infection. Nine week-old female C57BL/6 mice weighing 18-20 
g underwent a 20% total body surface area (TBSA) burn injury as previously described (34). Briefly, 
mice were anesthetized with gaseous isofluorane, their dorsal flanks were shaved, and they received a 
subcutaneous injection of morphine sulphate prior to receiving a full-thickness burn with 4 applications of 
a copper rod heated in boiling water. Following burn injury, mice were resuscitated via an intraperitoneal 
injection of lactated Ringer’s solution. Throughout the experiment, mice were monitored and received 
morphine in their drinking water (0.02 mg mL-1; 4 mg kg-1 body weight per day) ad libitum. Sham (0% 
TBSA) mice also underwent these treatments, except the application of the copper rod.  
At 14 d following burn injury, pneumonia was induced via the intratracheal administration of 50 
L Pseudomonas aeruginosa (PAK strain) following sedation with Avertin. Uninfected groups were 
administered 50 L PBS with 1% protease peptone in the same manner. At 48 h following infection, ~300 
L blood was drawn into EDTA-coated microcentrifuge tubes via submandibular puncture. This blood 
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was immediately injected into the microfluidic device and analyzed amperometrically to determine NO 
concentrations. 
Microfluidic amperometric sensor for nitric oxide measurement. Devices were fabricated as 
previously described (28). Working electrodes were 100 µm wide and consisted of 150 nm thick platinum 
with a 10 nm titanium seed layer, coated with a selective film (adhesion layer of 1% v/v (3-
aminopropyl)triethoxysilane and a fluoroalkoxysilane xerogel) to impart selectivity to NO. The 
fluoroalkoxysilane membrane solution was prepared via the acid catalyzed hydrolysis and condensation 
of (heptadecaﬂuoro-1,1,2,2-tetrahydrodecyl)trimethoxysilane and methyltrimethoxysilane as reported 
previously (35, 36). Reference electrodes consisted of a 10 nm titanium adhesion layer followed by a ~1 
µm silver layer, chemically oxidized by reaction with 50 mM ferric chloride for 10 s to create a 
silver/silver chloride pseudo-reference/counter electrode. The ~90 µm microfluidic channel was formed 
using Kapton® tape. 
The working and reference/counter electrodes of the microfluidic device were connected to a CH 
Instruments 1030A 8-channel potentiostat (Austin, TX). Prior to sample analysis, the device was 
polarized at +800 mV vs. the Ag/AgCl pseudo-reference/counter electrode for at least to 1 h in PBS. To 
calibrate the device, a saturated NO standard solution (prepared by purging deaerated PBS with NO gas 
for ~10 min to yield a 1.9 mM solution of NO) was diluted with PBS and introduced into the inlet 
reservoir. 
Statistical analysis. Where appropriate, either an unpaired, two-tailed Student’s t-test or two-way 
ANOVA with Bonfennori post-test was used to determine statistical significance between groups, with p 
<0.05 considered to be significant. 
Results 
Nitric oxide levels are increased during pneumonia without prior burn injury. Blood samples 
were drawn 48 h following infection with 1 x 106 CFU of P. aeruginosa and immediately analyzed using 
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the microfluidic sensor (Figure 2.1). As shown in Figure 2.2A, blood NO levels were significantly 
increased in the infected versus uninfected mice at this time point (810  180 nM and 370  40 nM, 
respectively). As expected, these data suggest that activation of the immune response following infection 
leads to increased production of NO. 
Increased infectious dose corresponds with elevated serum NO.  Blood samples were drawn 24 h 
and 72 h following infection with either 5 x 105 or 5 x 106 CFU of P. aeruginosa.  As indicated in Figure 
1B, blood NO levels were higher in uninjured mice exposed to a higher infectious dose at 24 h (3.0  0.2 
µM vs. 6.2  0.7 µM) and 72 h (7.0  1.4 µM vs. 15.2  4.7 µM) following infection.  At both high- and 
low-dose inocula, blood NO concentrations were higher at 72 h than at 24 h. We also harvested lungs and 
quantified bacterial load in these mice at 72 hours after infection. There was a significant difference in 
bacterial load between mice with high and low dose bacterial inoculum, with a corresponding significant 
difference in plasma NO levels (Figure 2.2B). 
Burn injury inhibits nitric oxide release following infection. Blood samples from infected (5 x 106 
CFU) and uninfected mice 14 d after burn injury were analyzed using the electrochemical sensor. 
Concentrations of NO in blood of infected burned mice were not significantly elevated compared to 
uninfected burn mice (290  80 nM vs. 410  110 nM) (Figure 2). We also harvested lungs and quantified 
bacterial load in these mice at 72 hours after infection, and observed a significant reduction in pulmonary 
bacterial clearance in burn mice compared to sham mice and corresponding reduction in NO (Figure 2.3). 
These data indicate a late-stage effect of burn injury on immune function and NO production during an 
infection. Also of note, the NO concentrations observed in uninfected burn mice were equivalent to those 
in the uninfected sham mice.  
We measured blood NO levels at 24 h and 72 h following a low-dose (5 x 105 CFU) infection 
with P. aeruginosa, and observed that NO concentrations were lower in burn infected mice compared to 
unburned infected mice at both 24 h (1.1  0.4 vs. 3.0   0.2 μM) and 72 h (6.0  0.6 vs. 7.0   1.4 μM) 
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following the infection (Figure 2.4A).  Following inoculation with a high-dose (5 x 106 CFU) of P. 
aeruginosa, we observed elevated blood NO in burned mice compared to unburned mice at 24 h (7.5  
0.7 μM vs. 6.2   0.7 μM), however while blood NO continued to rise in unburned mice, NO was not 
increased in burned mice at 72 h (4.2  2.0 μM vs. 15.2   4.7 μM) post infection (Figure 2.4B).   
Discussion 
In this study, we evaluated the effect of infection and burn injury on endogenous NO levels in a 
murine model. It is well understood that NO, along with other reactive oxygen and nitrogen species (ROS 
and RNS), are produced at higher levels during infection. Until recently, direct detection of NO has not 
been possible and analysis of its byproducts (nitrate and nitrite) has been required to estimate NO 
production. The microfluidic electrochemical sensor utilized herein allows for the immediate and direct 
detection of NO in a small (~250 µL) volume of whole blood, without the addition of external reagents. 
During an infection with no previous trauma, NO levels were increased relative to control mice. This 
result is not surprising, as NO is known for its antibacterial activity (37) and has been previously 
demonstrated to increase during systemic infection (28). We therefore conclude that our novel monitor 
sensitively detects changes in endogenous NO during nonlethal infection in mice.  
However, this trend was not observed or was attenuated during infection that occurred 14 d 
following burn injury. Indeed, NO concentrations in infected burn mice were equivalent to those of 
uninfected burn and sham mice, suggesting immune suppression as a result of the burn injury.  Even 
following high dose infection, when at 24 h NO concentrations were higher in burn than unburned mice, 
the injured mice were unable to sustain a robust response and NO concentrations diminished by 72 h 
compared with unburned mice.  
The dysfunctional immune response following burn injury has been well documented (2). Cairns 
et al. demonstrated that while expression of TLR2 and TLR4 by macrophages is increased early (3 d) 
following burn injury, these levels are significantly decreased at 14 d (38). Numerous immune defense 
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systems are linked to TLR, including the induction of iNOS (39). Other studies have linked TLR with the 
induction of iNOS and concomitant release of NO by innate immune cells (e.g., macrophages) (40-42). 
For example, TLR is directly involved in microbe recognition by innate immune cells (TLR2 for Gram-
positive peptidoglycan and TLR4 for Gram-negative lipopolysaccharide) and thus mediates subsequent 
inflammatory signals, including NO (39).  Future studies should determine whether TLR signaling is 
directly linked to endogenous NO following infection.  
While increased levels of endogenous NO may indicate development of a severe infection in 
otherwise healthy animals, the immune dysfunction that occurs late after trauma (e.g., burn injury) 
significantly alters NO production. As such, monitoring in vivo NO production in real time may provide 
insight into emerging infection as well as immune dysfunction. Reduction in NO production by innate 
immune cells, along with other aspects of immune suppression (e.g., shifts in T cell phenotype (43), 
altered cytokine profiles (44)), contribute to the increased infection susceptibility of burn patients. The 
clinical utility of NO measurement can be further evaluated by monitoring concentration changes 
throughout the course of infection/sepsis and throughout the dynamic immune response following trauma. 
In murine models, differences in NO concentration caused by infection with more virulent strains and 
during antibiotic treatment must also be evaluated. 
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FIGURES 
 
Figure 2.1: Experimental design for burn injury, infection, and blood NO analysis. 14 days after 
burn or sham procedure, mice were infected via intra-tracheal inoculation with P. aeruginosa and blood 
NO and bacterial burden in the lung was quantified at 24-72h after infection.  
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Figure 2.2: Nitric Oxide (NO) levels are elevated following infection without prior injury in a dose-
dependent fashion.  Mice (n=4) were infected with of P. aeruginosa and blood NO analyzed. A) NO 
levels were significantly increased 48 h following infection with1 x 106 CFU compared to uninfected 
counterparts. Statistical significance is indicated by *, p < 0.05 by a Student’s t test. B) NO levels in 
blood and bacterial recovery from lungs were higher in mice inoculated with 5 x 105 CFU vs. 5 x 106 
CFU at 72 hours post infection.  Statistical significance is indicated by *, p<0.05 and ***, p < 0.001 by 
Two-way ANOVA with Bonfennori post-test. Data are given as mean  standard deviation.  
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Figure 2.3: Relative to sham mice, burn injury causes decreased blood NO concentrations and 
increased pulmonary bacterial load following a 14 d post-burn infection. Mice (n=4) were infected 
with 5 x 106 CFU of P. aeruginosa 14 d after injury and blood NO analyzed 72 h after infection. 
Statistical significance is indicated by *, p<0.05 and ***, p < 0.001 by a Two-way ANOVA followed by 
Bonfennori post-test (A) and Student’s t-test (B). Data are given as mean  standard deviation. 
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Figure 2.4:  Inoculation dose impacts blood NO concentration in burn mice following infection. 
Mice (n=3-4) were infected with A) 5 x 105 or B) 5 x 106 CFU of P. aeruginosa and blood NO analyzed 
after 24 h or 72 h. Statistical significance is indicated by ***, p < 0.001 by a Two-way ANOVA followed 
by Bonfennori post-test. Data are given as mean  standard deviation. 
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CHAPTER 3: MAMMALIAN TARGET OF RAPAMYCIN REGULATES A HYPER-
RESPONSIVE STATE IN PULMONARY NEUTROPHILS LATE AFTER BURN 
INJURY.1  
Summary 
Bacterial pneumonia is a leading cause of death in burn patients, highlighting the severe immune 
dysfunction that follows traumatic injury. Metabolism is also perturbed in burn patients; we therefore 
examined the interplay between metabolism and innate immunity in the context of burn injury by 
suppressing the mammalian target of rapamycin (mTOR) in a murine model of burn injury.  Following 
burn injury, we observe recruitment of neutrophils to the lungs, accompanied by increased ex 
vivo reactive oxygen and nitrogen species (RONS) production by neutrophils. Elevated RONS production 
correlates with improved clearance of Pseudomonas aeruginosa, despite burn-dependent downregulation 
of TLR2 and TLR4 expression on granulocytes. mTOR inhibition prevented the enhanced bacterial 
clearance in injured mice, and caused overwhelming mortality in burn mice after high-dose infection. 
Rapamycin treatment did not alter neutrophil recruitment to the lung in either injured or infected animals; 
however, oxidative burst was decreased by rapamycin treatment. Our results indicate the importance of 
RONS activity following burn injury, and illustrate that neutrophil activity within the lung tissue is more 
important than recruitment for infection clearance following cutaneous burn injury.  
Introduction 
In 2015 almost 500,000 patients sought medical care for a burn injury in the United States, 
resulting in approximately 40,000 Intensive Care Unit admissions and over 3,000 fatalities.   Severe burns 
                                                           
1 Attribution: Julia Dunn designed and carried out experiments, analyzed data, created figures, and wrote 
manuscript.  Karli Gast, Marci Sessions, and Rebecca Hunger analyzed data and created figures.  Lance Thurlow 
administered rapamycin and carried out associated experiments.   
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often require several weeks of hospitalization, during which patients require careful monitoring to prevent 
and treat infections (1, 2). Burn injury leads to immune perturbations that render patients highly 
susceptible to opportunistic bacterial infections during recovery. Indeed, patients without apparent lung 
damage at admission often develop bacterial pneumonia during hospitalization, most often due to 
Pseudomonas aeruginosa.  Improved understanding of the complex immune response to burn injury may 
illuminate treatments to minimize complications, decrease recovery times, and improve long-term 
prognosis.  
The immune response to burn injury is complex and dynamic. For years it was believed that in 
burns, as in sepsis, patients experience an initial Systemic Inflammatory Response Syndrome (SIRS) 
marked by pro-inflammatory cytokines and other inflammatory mediators.  In sepsis, SIRS is followed by 
a later, Compensatory Anti-Inflammatory Response Syndrome (CARS) where immunosuppression 
renders the patient vulnerable to infection.  Recent studies indicate that the SIRS/CARS paradigm may 
not accurately represent the complex immune response in burn patients because pro- and anti- 
inflammatory mediators are often detected simultaneously  (1-6).  Several animal models of burn injury 
have been described, including scalds, contact burns, and flame burns in pigs, rats, and mice (7-10). 
While the preponderance of animal studies has focused on the early immune response following injury, 
animal studies focused on the late immune response have been infrequent and do not show clear 
immunosuppression.  
Following traumatic injury, patients experience severe metabolic dysregulation, characterized by 
elevated basal metabolic rate and a paradoxical comingling of hyperglycemia and hyperinsulinemia (2, 9, 
11, 12). Several studies have demonstrated altered metabolism in animal models of burn injury (13-15). 
The relationship between metabolism and immunity has been focus of much recent research activity (16, 
17).  Insulin receptor signaling suppresses Toll-like Receptor (TLR) expression in human granulocytes 
(18) and hyperglycemia perturbs both cytokine secretion and TLR signaling in myeloid cells (19-22).  
Insulin receptor signaling leads to mTOR activation, allowing cells to interpret nutrient availability to 
 42 
support translational and metabolic processes that lie downstream of mTOR (23). mTOR responds to 
signaling via TLR and chemokine receptors on innate immune cells (24), however the importance of 
mTOR signaling in antimicrobial activity by neutrophils has not been clearly elucidated.   
We hypothesize that mTOR activity promotes innate immune cell function late after a cutaneous 
burn injury.  Using systemic administration of rapamycin in a murine model of contact burn, we observed 
an mTOR-dependent decrease in neutrophil function in the lung following injury.  These changes resulted 
in decreased bacterial clearance and survival following a pulmonary P. aeruginosa infection.  
Methods 
Burn injury and rapamycin treatment. Nine week old Female C57/BL6 mice (Taconic Farms; 
Hudson, NY) were housed in a specific pathogen free environment.  All procedures were carried out in 
accordance with guidelines from the National Institutes of Health regarding use of vertebrate animals in 
research. Protocols were approved by the University of North Carolina at Chapel Hill’s Institutional 
Animal Care and Use Committee. Based on previous studies and IACUC recommendations to limit 
animal numbers, 3-4 sham and 4-5 burn animals were used for experiments without infection; for 
infections studies 4-5 sham and 5-6 burn mice were used per group.  Experiments were repeated to 
confirm findings and representative data are shown.  
The 20% total body surface area full-thickness contact burn procedure was carried out under 
isofluorane sedation as previously described, including prophylactic subcutaneous morphine prior to 
injury and oral morphine ad libitum in drinking water following injury (25). Rapamycin was administered 
(4 mg/kg/d) daily starting 7 d before the burn injury via an intraperitoneal injection.  
Infection and sample collection. Pseudomonas aeruginosa strain PAK was grown until mid-log 
phase in LB broth.  Bacteria were pelleted, washed, and suspended with ice cold protease-peptone in 
phosphate buffered saline (1% by weight; PP-PBS). Mice were sedated with tribromoethanol (475mg/kg 
body weight. Sigma-Aldrich; St. Louis, MO), sedation was confirmed by toe-pinch, and mice were 
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mounted on an intubation platform. A MicroSprayer® Aerosolizer Model 1A-1C and FMJ-250 High-
Pressure Syringe (Penn Century, Inc.; Wyndmoor, PA) nozzle was inserted into the trachea and 50μL of 
aerosolized inoculum or vehicle control (1% PP-PBS) was instilled into the airway.   
Levels of nitric oxide (NO) were measured directly in blood as previously described (26).  To 
determine bacterial burden, lung and liver tissue were collected at time of sacrifice and serial dilutions of 
tissue homogenate in PBS were plated on LB-agar plates and grown overnight at 37˚C.  
To prepare tissue for histology, lungs were inflated with paraformaldehyde (4% by weight in 
PBS) to a constant pressure and fixed overnight.  Lungs were embedded in paraffin, sectioned, and 
hematoxylin and eosin (H&E) stained at the Lineberger Comprehensive Cancer Center Animal 
Histopathology Core. Images were taken with an Olympus BX61 Upright Wide Field Microscope at the 
UNC Microscopy Services Laboratory.   
Flow cytometric analysis. Lung tissue was minced and digested with collagenase I (4.5 mg) and 
DNAse (2 ug) with shaking for 1 h at 37˚C.  Filtered samples were subjected to ACK lysis and treated 
with a blocking immunoglobulin against CD16/CD32 (eBioscience; San Diego, CA) prior to staining 
with fluorescently conjugated antibodies against CD45, CD11b, CD11c, Ly6C, Ly6G, and F4/80 (BD 
Biosciences; San Jose, CA).  To quantify RONS production, stained cells were incubated with 0.75 mg 
Dihydrorhodamine 123 (DHR; Thermo-Fischer; Waltham, MA).  Duplicate samples were either 
stimulated with 62.5 ng phorbol 12-myristate 13-acetate (PMA) or left unstimulated.  After 30 min, 
reactions were quenched with a fixation buffer containing 1% paraformaldehyde and mean fluorescence 
intensity (MFI) was measured.  Samples were analyzed at the UNC Flow Cytometry Core Facility on a 
CyAn and Summit 5.3 software was used to analyze data (Beckmann-Coulter; Indianapolis, IN). 
Neutrophils were defined as CD45+CD11b+CD11c-Ly6G+ and macrophages were defined as 
CD45+CD11c+Ly6C+F4/80+Ly6G-.  
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Statistical analysis. GraphPad Prism Version 5.0 for Windows was used to analyze data by 
Student’s t-Test, One-Way Analysis of Variance (ANOVA) with Tukey post-test, or Two-Way ANOVA 
with Bonferroni post-test, as appropriate.  Data are represented as mean +/- standard error of the mean 
(SEM). 
Results and Discussion 
Burn injury leads to sustained recruitment of neutrophils to the pulmonary vasculature. The most 
common cause of mortality amongst burn patients late after injury is bacterial pneumonia. In order to 
characterize the immune environment of the lung, we performed cutaneous burn or sham injury on 
wildtype C57BL/6 mice. Using flow cytometry, we observed that neutrophils are recruited to the lung 
within hours of the injury (Figure 3.1A), and absolute numbers remain high for two weeks (Figure 3.1B). 
Figure 1C shows a representative flow plot of Ly6g-Ly6C+F4/80+ macrophages and Ly6g+Ly6C-F4/80- 
neutrophils after gating on CD45+ and excluding CD11b-CD11c- cells. The gates were used to calculate 
the frequency of neutrophils, which increased approximately five-fold in the lung compared to sham 
injured mice at 14 days post injury (dpi). We did not observe an increase in macrophage numbers or 
frequency in the lung following burn injury (Figure 3.1D). Histology revealed that the neutrophils are 
sequestered in the lung vasculature, with no appearance of neutrophils, edema, or other damage in the 
airway or alveolar space (Figure 3.1E). 
Neutrophils that accumulate in the pulmonary vasculature after burn have greater oxidative 
activity ex vivo. In order to determine whether burn injury alters the function of innate immune cells in the 
lung, we quantified reactive oxygen and nitrogen species (RONS) production by cells isolated from whole 
lung 14 d after cutaneous burn injury. We utilized Dihydrorhodamine-123 (DHR) to detect the production 
of both reactive nitrogen and oxygen species in cells (27). In burned mice compared to sham we observed 
a significant increase in the ability of neutrophils to oxidize DHR without further stimulation ex vivo 
(Figure 3.2A). Stimulation with PMA revealed that the maximal RONS production was equivalent in 
burn and sham neutrophils, resulting in a significantly reduced stimulation index (stimulated 
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MFI/unstimulated MFI; Figure 3.2B). Neither resting nor maximal RONS production was altered in lung 
macrophages after burn injury. These data suggest that pulmonary neutrophils, which accumulate late 
after burn injury, likely have hyper-responsive oxidative activity in vivo. 
Burn mice clear bacterial infection more effectively than sham injured mice despite reduced TLR 
expression. We hypothesized that the increased oxidative capacity of neutrophils late after injury accounts 
for the ability of burned mice to clear a pulmonary bacterial infection. We inoculated burn or sham 
injured mice 14 d after injury with aerosolized Pseudomonas aeruginosa (strain PAK), a clinically 
relevant opportunistic pathogen that frequently causes fatal pneumonia in burn patients. We observed a 
significant increase in the clearance of PAK in burn mice compared to sham mice, despite comparable 
increases in neutrophil numbers in the airway (Figure 3.3A). On examination of the innate cell activity in 
the lung, we found that both burn injury alone and burn injury plus infection resulted in elevated RONS 
production by pulmonary neutrophils ex vivo; however, we did not observe an infection-dependent 
increase in neutrophil RONS production in either burn or sham animals (Figure 3.3B). In contrast, only 
bacterial infection significantly increased RONS by pulmonary macrophages. These findings suggest that 
the increased oxidative capacity of neutrophils late after injury is maintained during bacterial infection. 
Toll-like receptor (TLR) signaling is an important sensing mechanism for antimicrobial 
responses. We have previously described reduced TLR expression by innate cells late after burn injury 
(8).  Other studies have shown that TLR2 and TLR4 signaling impact neutrophil chemotaxis, activation, 
and lifespan, with the latter effects being especially important for prolonged responses to stimulus as in 
the case of our model (28). Herein, using flow cytometry, we observe significantly reduced TLR2 and 
TLR4 expression in burn mice compared to sham at 14 d after injury (Figure 3.3C). These changes in 
TLR expression occurred with and without infection. The ability of burn mice to clear pulmonary bacteria 
therefore appears more tightly correlated with oxidative burst than TLR expression.  
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Inhibition of mTOR reverses burn injury-induced innate immune hyper-responsiveness in the 
lung. It has been proposed that mTOR activity impacts neutrophil recruitment, RONS production and 
TLR signaling (24). mTOR can act downstream of the insulin receptor, making it a target of 
hyperinsulinemia observed in burn patients (29).  Furthermore, processes downstream of mTOR 
activation, such as oxidative burst and protein translation, are enhanced by hyperglycemia (30-32).  
Because of the importance of mTOR and its signaling partners in insulin signaling and immune 
regulation, we hypothesize that mTOR promotes granulocyte hyper-responsiveness following trauma and 
infection by boosting TLR sensitivity and RONS production. To test this hypothesis, we inhibited mTOR 
activity with systemic administration of rapamycin and measured bacterial clearance as well as TLR 
expression and RONS production by pulmonary granulocytes following injury (Figure 3.4). 
We observed increased bacterial burden in rapamycin treated burn mice compared to rapamycin 
treated sham mice (Figure 3.5A). At a high infectious dose, we observed significant mortality within 72 h 
of infection only in burn injury and rapamycin treated mice (Figure 3.5B). We have previously reported 
that increased blood nitric oxide (NO) marks a robust innate response to bacterial infection (26). Using a 
novel microfluidics based electrode to rapidly detect blood NO, we found that sham injured mice were 
able to mount a significantly increased NO response after PAK infection.  In contrast, burn mice infected 
14 d after injury had a significant reduction in the concentration of blood NO compared to infected sham 
mice.  mTOR inhibition suppressed systemic NO production following infection in both sham and burn 
mice (Figure 3.5C).  
We explored the cellular mechanism of the decreased bacterial control and increased mortality 
following burn plus rapamycin treatment.  Rapamycin did not impact neutrophil or macrophage 
recruitment to the lungs in any treatment group (data not shown).  Neutrophil and macrophage TLR 
expression was reduced by rapamycin treatment in both sham and burn injured mice (Figure 3.6A).  
Future studies should determine whether signal transduction downstream of TLR ligation is similarly 
impaired by rapamycin treatment.  We found that in neutrophils (Figure 3.6B) and macrophages (Figure 
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3.6C), increased RONS production after burn and infection was dependent on mTOR; however, there was 
a further burn-dependent decrease of RONS production by neutrophils, evidenced by a reduced 
stimulation index, which was independent of mTOR activity (Figure 3.6B).  
In conclusion, we report substantial neutrophil accumulation in the lung following burn injury, 
accompanied by increased RONS production and minimal extravasation into the airway. In contrast, 
macrophages are not “primed” by burn injury in this way. When challenged with a pulmonary bacterial 
infection, we observe enhanced bacterial clearance in burn mice compared to uninjured controls, 
accompanied by increased RONS production by both lung neutrophils and macrophages even in the face 
of reduced TLR expression.  Augmented RONS production, but not granulocyte recruitment, was 
abolished by mTOR inhibition after burn injury. The absence of the innate “priming” effect of burn injury 
in rapamycin-treated mice led to increased bacterial susceptibility in burn mice compared to uninjured 
controls.  After burn injury, reduced TLR expression and mTOR-inhibition suppresses the burn-
dependent increase in RONS production by innate cells.  We hypothesize that after burn injury, 
accelerated metabolism increases mTOR signaling, priming innate immune activity to protect the airway 
from infection by driving up innate cell RONS production. In this study oxidative burst appears to be 
more important for bacterial clearance than granulocyte recruitment because mTOR suppression led to 
increased bacterial burden.   It may be more therapeutically beneficial to target innate immune effector 
function rather than recruitment in trauma patients.  Future studies will determine whether systemic 
agonists of AMPK and HIF1α, which act up- and downstream of mTOR, respectively (23, 24), are 
effective in offsetting pneumonia after burn injury in mice.  Additional studies are underway to quantify 
factors that impact mTOR signaling in trauma patients. 
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FIGURES 
 
Figure 3.1: Neutrophils are recruited to the lung following burn injury. A) Neutrophils are shown as 
a percentage of CD45+ cells from whole lung tissue as measured by flow cytometry. B) Total number of 
neutrophils in the lung is determined as (%neutrophils as live cells x live cells counted at harvest). C) 
Representative Ly6g-Ly6C+F4/80+ macrophages and Ly6g+Ly6C-F4/80- neutrophils flow plots after 
gating on CD45+ and excluding CD11b-CD11c- cells.  D) Neutrophils and macrophages are shown as a 
fraction of live cells as measured by flow cytometry. E) Representative specimens of H&E stained distal 
airway are shown from sham and burn mice at 12 h after treatment. Data shown are +/-SEM.  Samples 
were analyzed by Student’s t-test and significance indicated by *p<0.05, **p<0.01.  
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Figure 3.2: Burn injury impacts reactive oxygen and nitrogen species (RONS) production in 
neutrophils. Cells from whole lung tissue were collected at 14 d post-injury and analyzed by flow 
cytometry. A) DHR MFI of gated neutrophils or macrophages was measured in unstimulated samples. B) 
DHR MFI was measured in gated neutrophils and macrophages from paired stimulated and unstimulated 
samples.  Stimulation index was calculated by dividing the DHR MFI of stimulated samples by that of 
unstimulated samples. Data shown are +/-SEM.  Data were analyzed by Two-way ANOVA with 
Bonferroni post-test (A) or Student’s t-test (B) and significance denoted as *p<0.05.  
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Figure 3.3: Changes in immune function, but not recruitment, lead to improved bacterial clearance 
in the lung following burn injury. Mice were infected intratracheally with 1× 106 CFU of PAK at 14 dpi 
and samples were collected 48 h later. A) Bacterial burden in whole lung homogenate was observed in 
burn mice compared with sham mice.  B) DHR MFI of gated pulmonary neutrophils or macrophages 
from both stimulated and unstimulated samples was measured by flow cytometry. Unstimulated values 
are shown, as well as the stimulation index (DHR MFI stimulated / DHR MFI unstimulated) C) MFI of 
PE-labeled TLR4 on gated neutrophils and TLR2 on gated macrophages was determined by flow 
cytometry in samples from lung. Data shown are +/-SEM.  Data were analyzed by Two-way ANOVA 
with Bonferroni post-test or Student’s t-test and significance indicated as *p<0.05, **p<0.01.  
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Figure 3.4: Experimental design for rapamycin administration, burn injury, infection, and analysis.  
Rapamycin was administered via intraperitoneal injection (4mg/kg/d) starting 1 week prior to burn or 
sham procedure.  Mice were infected with P. aeruginosa via intratracheal inoculation 2 weeks following 
injury, and tissues were harvested for analysis between 24 and 72h later.   
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Figure 3.5: mTOR activity is required for survival and efficient bacterial clearance in burned mice 
following infection. Mice underwent an intra-tracheal inoculation with PAK at 14 dpi. A) 48 hours 
following infection with 1 × 106 CFU of PAK, bacterial burden was determined in whole lung 
homogenate.  B) Following infection with 5 × 106 CFU of PAK, mice were monitored for morbidity for 
72h, and moribund or deceased animals were recorded. C) Blood from the submandibular vein was 
collected and NO levels were directly measured. Data were analyzed by Student’s T-test or two-way 
ANOVA with Bonferroni post-test and are represented as mean +/-SEM. *p<0.05, **p<0.01, *** p < 
0.001.  
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Figure 3.6: mTOR inhibition impacts innate immune function following burn injury and infection. 
Mice underwent an intra-tracheal inoculation with 1 × 106 CFU PAK at 14 dpi., with or without 
Rapamycin treatment. A) MFI of PE-labeled TLR2 on neutrophils and macrophages from whole lung cell 
suspensions was determined by flow cytometry. B-C), DHR MFI of gated pulmonary B) neutrophils and 
C) macrophages from both stimulated and unstimulated samples was measured by flow cytometry. 
Unstimulated values are shown, as well as the stimulation index (DHR MFI stimulated / DHR MFI 
unstimulated). Data were analyzed by two-way ANOVA with Bonferroni post-test and are represented as 
mean +/-SEM. *p<0.05, **p<0.01.   
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CHAPTER 4: DAMPS IN CIRCULATION FOLLOWING TRAUMA PROMOTE 
INFLAMMATION IN THE LUNG  
Summary 
Acute lung injury (ALI) in patients who have experienced severe trauma with no direct lung 
insult is thought to be caused by release of damage associated molecular patterns (DAMPs) from injured 
tissue into circulation.  Existing murine models of ALI rely on either a pathogenic signal or direct injury 
to the lung and have therefore failed to accurately model patients developing ALI after burns without 
smoke inhalation.  To test the hypothesis that DAMP release precipitates ALI and optimize a murine 
model of ALI that is driven by systemic DAMPs, we intravenously administered components of the 
extracellular matrix or mitochondrial fragments and quantified accumulation of protein and live cells in 
the airway.  A 20% total body surface area burn injury, alone, did not cause significant airway 
inflammation, nor did administration of DAMPs to unburned mice.  When administered following a burn 
injury, however, mitochondrial homogenate (MTD) and hyaluronic acid (HA) led to increased cells and 
protein in the BALF.  Purified mitochondrial DNA, alone, did not amplify inflammation in burned mice, 
however it increased cellular recruitment to the airway when co-administered with HA.  Collectively, 
these results indicate that sufficient damage patterns in circulation can not only promote neutrophil 
accumulation in the pulmonary microvasculature but can ultimately lead to extravasation of neutrophils 
into the lung. Future studies using this model will determine the molecular mechanisms that sense 
DAMPs and the downstream effects of this detection on cytokine and chemokine production and 
leukocyte function.  
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Introduction 
Traumatic injury results in destruction of cells and tissue and the release of molecular signals that 
are recognized as signals of damage and are therefore known as damage-associated molecular patterns 
(DAMPs).  For example, genetic material is normally sequestered inside cells, however lytic cell death 
and some forms of programmed cell death cause DNA to be released from the cell –the presence of 
extracellular DNA is therefore a signal of tissue stress or damage, acting on Toll-like receptor 9 to trigger 
activation of MyD88 and induction of IL-6 and IL-10 (1, 2). In addition to intracellular molecules that can 
act as DAMPs, extracellular molecules can be modified to signal tissue damage.  Hyaluronic Acid (HA) is 
the main component of the extra-cellular matrix and exists in a high molecular weight (HMW) form under 
physiological circumstances. HA is subject to degradation by proteases, reactive oxygen species, and 
mechanical stress resulting in medium molecular weight (MMW) fragments (3-5). MMW HA is 
recognized by Toll-like receptor 4 (TLR4) and has a potent effect on granulocyte function, especially 
phagocytosis, at a wide range of concentrations in both blood and tissue (5, 6). Changes in leukocyte 
function, including adhesion, extravasation, and activation, that occur in response to DAMP signaling 
may account for systematic damage following localized injuries.  
Several studies have identified DAMPs in patient biofluids after severe injuries.  Hyaluronic acid 
(HA) is elevated in trauma patient serum within the first three days of the injury, returning to normal 
levels at the end of two weeks (7). Both HA and dsDNA are elevated in BALF of patients with 
inhalational injury, especially those who have, or who go on to develop, bacterial pneumonia (8). It is 
unknown whether dsDNA in this study was derived from mtDNA released by stressed cells or nuclear 
DNA released by necrotic cells.  Mitochondrial DAMPs were observed in serum following large bone 
fractures and mtDNA concentrations in serum after trauma have been correlated with adverse patient 
outcomes (9, 10). Collectively, these studies indicate that DAMP concentration is positively correlated 
with injury severity. 
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Patients who experience severe trauma without direct insult to the lungs are at significant risk of 
developing ALI, marked by impaired oxygen exchange and the presence of pulmonary infiltrates (11, 12). 
Injuries such as these may include severe burns affecting greater than 30% of the total body surface area 
(TBSA) or compounded injuries (i.e. burn + bone fractures or blunt force trauma) (13, 14).  Attempts to 
generate murine models of ALI in injuries such as these, which result from systemic damage, have 
struggled because of the technical challenge of ethically conducting mouse burns greater than 20% 
TBSA, since these injuries require extensive pain control and supportive care.  Although a 20% TBSA 
burn in mice leads to accumulation of neutrophils in pulmonary microvasculature, it does not lead to 
perturbation of the alveolar/capillary barrier (15).  A murine model would enable deeper understanding of 
the cellular and molecular determinants of disease and represent a powerful tool for developing 
therapeutic interventions.   
Recently it was shown that systemic administration of mitochondrial DAMPs (MTD) consisting 
of homogenized mitochondria resulted in ALI in a mouse model (9). In the same report, MTD were 
shown to stimulate neutrophil degranulation, cytokine production, and migration in vitro (9). Because 
MTD contains dsDNA in the form of mtDNA, we sought to determine whether MTD or mtDNA could 
act as DAMPs in our model (Figure 4.1).  We also investigated the ability of MMW HA to induce an 
inflammatory response, alone and in combination with mtDNA (Figure 4.1). Our results indicate that 
neither DAMP administration nor burn injury, alone, are sufficient to disrupt the alveolar/capillary 
barrier; however, combined insults significantly increased protein concentration and live cell numbers in 
BALF.  These data confirm the feasibility of modeling ALI in mice without a direct lung insult or 
microbial signal.  
Methods 
Mouse housing and burn injury. Female C57/B6 mice purchased from Taconic farms were 
housed in a specific pathogen-free facility.  Burn and sham procedure were carried out as previously 
described (16). Briefly, mice were anesthetized with gaseous isofluorane and their dorsums were shaved 
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prior to subcutaneous administration of morphine.  A copper rod heated in a boiling water bath was used 
to administer a full-thickness 20% total body surface area contact burn and mice were resuscitated with an 
intraperitoneal injection of lactated Ringer’s solution.  Sham mice were not exposed to the copper rod; all 
mice received morphine in their drinking water ad libitum.  
DAMP preparation and administration. Medium molecular weight (MMW) HA was purchased 
from Fischer Scientific (Cat no: GLR004) and resuspended to 1 mg/mL in PBS. Dilutions were prepared 
in PBS prior to administration. Intranasal administration was accomplished in 50uL volumes and 
intravenous doses were 200uL.   
Mitochondria were isolated from liver tissue using a Mitochondrial Isolation Kit purchased from 
Fischer Scientific (Cat no: PI89801) per the manufacturer’s instructions.  To prepare MTD, mitochondria 
were suspended in 1mL PBS and sonicated ten times for 30 s.  Large debris was removed by 
centrifugation, and protein content was determined by Bradford assay.  Average protein concentration per 
homogenized liver was calculated in order to calculate a dose equivalent to 5% of the liver (9). mtDNA 
was isolated from mitochondria using a QIAGEN DNA extraction kit, resuspended in PBS, and 
quantified using a nanodrop.  mtDNA was sonicated at 2 second intervals for a total of 10 seconds, and 
the efficiency of degradation was confirmed by running samples through an agarose gel.  Intravenous 
dosages were prepared in 200uL volumes.  
Sample collection and analysis. Mice were euthanized with gaseous isofluorane and BAL was 
collected with 3 washes of PBS containing 0.6 mM EDTA. Protein concentration was measured in 
supernatants from the first wash using a Bradford assay. Cell pellets from all 3 washes were combined 
and suspended in PBS with 10% FBS.  Live cells were counted using a hemacytometer and trypan blue 
stain.  
To enumerate neutrophils, cells were analyzed by flow cytometry.  Following incubation with Fc 
block (eBiosciences), cells were stained with antibodies against CD45, CD11b, CD11c, and Ly6G (BD 
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Biosciences; San Jose, CA). Samples were analyzed at the UNC Flow Cytometry Core Facility on a 
CyAn and Summit 5.3 software was used to analyze data (Beckmann-Coulter; Indianapolis, IN). 
Neutrophils were defined as CD45+CD11b+CD11c-Ly6G+.   
To quantify IL-6 in serum, blood was collected from the submandibular vein into EDTA-coated 
tubes prior to euthanasia.  Samples were centrifuged and serum was removed and frozen prior to analysis.  
1:1 dilutions of serum in PBS were analyzed via IL-6 ELISA (eBiosciences) per the manufacturer’s 
protocol.  
Statistical analysis. GraphPad Prism Version 5.0 for Windows was used to analyze data by 
Student’s t-Test, One-Way Analysis of Variance (ANOVA) with Tukey post-test, or Two-Way ANOVA 
with Bonferroni post-test, as appropriate.  Data are represented as mean +/- standard error of the mean 
(SEM).  
Results 
Hyaluronic acid. In order to measure the incidence of ALI, live cell count and protein 
concentration in BALF were measured in mice treated with vehicle or 2 ug MMW HA.   Intravenous 
administration of 2ug MMW HA in sham mice did not lead to a significant increase in either protein 
accumulation or cellularity in the airway at 12 h (Figure 4.2 A-B).  In contrast, administration of 1ug HA 
in burn mice causes a significant increase in protein concentration in the airway at 12h (Figure 4.2 C). 
Similarly, we observed an increase in live cell count in BALF 12h after burn and HA treatment (Figure 
4.2 D).  
To determine whether the route of administration would impact the inflammatory response to 
HA, intravenous administration was compared with intranasal administration in burn-treated mice.  No 
difference was observed in either protein concentration or neutrophil recruitment to the airway when mice 
were treated with intranasal HA compared with intravenous HA (Figure 4.2 E-F).   
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Mitochondrial DAMPs. It has been reported that intravenous administration of MTD causes ALI 
in a rodent model; we therefore sought to confirm this finding and to determine whether it is amplified by 
concomitant burn injury (9). In sham-treated mice, intravenous MTD administration caused an 
accumulation of live cells in the airway that did not achieve statistical significance (Figure 4.3 A). Burn 
and MTD treatment led to significantly more live cells in the BALF with the majority of those cells 
identified as neutrophils at 48h (Figure 4.3 A-B).  Increased cellularity in burn and MTD treated mice was 
sustained from 24-48h and was accompanied by an increase in protein concentration that did not achieve 
statistical significance (Figure 4.3 C-D).  We observed an acute (3-24h) increase in serum IL-6 in burn 
and MTD treated mice compared to shams (Figure 4.3 F).  
Several DAMPs may be present in mitochondrial lysate, including mtDNA, cytochrome C, and 
N-formylmethioline, therefore we set out to characterize the role of a specific DAMP in the inflammatory 
response. Previous studies have reported a link between concentrations of mtDNA in serum and outcomes 
in trauma patients (10). Because mtDNA is a part of the mitochondrial lysate that makes up MTD, we 
designed experiments to determine whether purified mtDNA rather than bulk mitochondrial homogenate 
could cause ALI.   Administration of 750 ng mtDNA after burn injury caused an increase in neutrophils 
but not protein in the airway at 48h (Figure 4.4 A-B). Because mtDNA exists in a supercoiled form, 
mtDNA was sonicated to produce smaller fragments.  Sonicated mtDNA did not increase protein leakage 
but induced slightly more live cell recruitment to the airway compared with unsonicated mtDNA (Figure 
4.4 C-D).  
Combined administration of mtDNA and HA. To determine whether there might be a synergistic 
effect of HA and mtDNA on development of ALI following injury, sonicated mtDNA and HA (MDH) 
were co-administered to burned mice.  To titrate the appropriate amount of mtDNA to administer with 
HA, 150 ng/mL, 400 ng/mL, and 1000 ng/mL of mtDNA were administered along with HA in burned 
mice and results were compared with vehicle control in uninjured mice.  Both medium and high dosages 
of mtDNA caused statistically significant increases in cellularity (Figure 4.5).  
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Discussion 
Severe traumatic injury has been shown to induce acute lung injury (ALI), even in the absence of 
a direct insult to the lung.  Injuries such as this include severe scalds, contact burns, or electrical burns 
where there was no smoke present at the time of injury.  Pulmonary inflammation elevates patients’ risk 
of contracting and succumbing to pulmonary infection.  To improve outcomes for such patients will 
require improved understanding of the molecular and cellular mechanisms that drive ALI in the absence 
of a direct pulmonary insult or pathogen challenge.  Existing studies have identified biomarkers of 
pathogenesis in animal models and human studies.    
It is known that complement activation in the serum following thermal injury leads to changes in 
the vascular epithelium and consequently enhanced interactions with platelets and leukocytes (15). TLR4 
ligation and signaling have also been shown to determine the onset and outcome of ALI (17, 18). These 
and other findings have failed to translate to the clinic because it has not been shown that they can be 
targeted without rendering patients severely immunocompromised.  
A systematic analysis of ALI following severe trauma has been impeded by the lack of an 
effective mouse model that recapitulates pulmonary inflammation without either a direct pulmonary insult 
or systemic shock with sepsis or administration of endotoxin. Importantly, ALI without direct lung injury 
is seldom observed in patients who present with less than 30% TBSA, and it is impossible to study burns 
greater than 20% TBSA in mice because of the technical difficulty of creating a murine intensive care 
unit, which would be required to ethically care for mice subjected to a more extensive injury (13, 14). We 
hypothesized that ALI following large burn injuries results from release of a high concentration of 
damage associated molecular patterns (DAMPs) from injured tissue into circulation.  We endeavored to 
test this hypothesis by administering DAMPs into circulation, alone or in concert with a thermal injury, in 
order to delineate the role of specific DAMPs on induction of pulmonary inflammation following trauma.   
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Although several studies have identified elevated DAMPs in patients and animals who develop 
ALI subsequent to trauma (8, 19), to our knowledge only one prior study has specifically tested whether 
intravenous DAMP administration could induce ALI (9). Mitochondrial homogenate (MTD) 
administration led to rapid increases in protein, IL-6, and live cells in BALF. Here we present data that 
indicates that combining burn injury and MTD administration amplifies accumulation of protein and 
neutrophils in the airway.  Unlike burn injury alone, which leads to accumulation of neutrophils in the 
pulmonary microvasculature and interstitial space but not the airway, MTD administration promotes 
neutrophil extravasation.  Although enriched mtDNA was not sufficient to reproduce the inflammatory 
phenotype observed with MTD, mtDNA in combination with HA led to similar increase in live cells in 
BALF samples.  We propose that co-administration of sonicated mtDNA and HA (MDH) is preferable to 
MTD as a model for ALI because the relevant molecular signals are more clearly defined than in whole 
mitochondrial lysate.   
The burn with MDH model presents an opportunity to address several important questions about 
the pathogenesis of ALI.  To more fully characterize the immune state of the injury, it will be important to 
examine chemokine and cytokine expression in the lung to determine signals that draw neutrophils into 
the airway.  Moreover, because HA and mtDNA are recognized by pattern recognition receptor (PRR) 
signaling, it will be important to evaluate the role of PRR ligation and signaling on leukocyte migration 
and cytokine production in this model.  Finally, a chief characteristic of ALI in trauma patients is that it 
renders them susceptible to pulmonary infection.  It will therefore be important in future studies to 
determine whether mice treated with burn and MDH are susceptible to infection in both acute and chronic 
phases after injury.   
The results of this research point to an important question about the role of DNA DAMPs in 
human ALI.  Although one report showed a positive correlation between serum mtDNA and injury 
severity, the authors did not examine the abundance of genomic DNA (10). Our studies have used 
fluorometric readouts to quantify double stranded DNA in patient serum that would not differentiate 
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between mtDNA and nuclear DNA, therefore it is unknown whether the dsDNA observed in patient 
serum results from stressed cells releasing mitochondrial contents or lytic cells releasing nuclear contents 
(8). One potential source of extracellular DNA is the production of neutrophil extracellular traps (NETs) 
which may contain either genomic DNA, mtDNA, or both (20). Moreover, different cellular signaling 
events drive the production of NETs enriched in genomic or mitochondrial DNA, therefore interfering 
with NETosis and, by extension, dsDNA enrichment in serum will benefit from understanding which 
pathways are at play.  Animal models have the potential to clarify causal relationships that can only be 
guessed at in patient samples and to test methods to manipulate the release and detection of DAMPs after 
injury to improve clinical outcomes.  
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FIGURES 
 
Figure 4.1: Experimental design for intravenous DAMP administration. After burn or sham injury, 
hyaluronic acid (HA), mitochondrial homogenate (MTD), and mitochondrial DNA (mtDNA) were 
administered via intravenous injection alone or in combination.    
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Figure 4.2: Hyaluronic acid administration leads to mild pulmonary inflammation after burn 
injury regardless of administration route. Live cells (A) and protein concentration (B) in the BALF of 
mice who received intravenous administration of either PBS or 2 mg HA.  Live cells (C) and protein 
concentration (D) in BALF of uninjured mice treated with PBS (open bars), burned mice treated with 
PBS (hatched bars), and burned mice treated with 1 mg HA (shaded, hatched bars).  (E) Live cells 
recovered from BALF of mice treated with HA via intravenous or intranasal exposure immediately after 
burn injury.  (F) Live cells recovered from BALF of burned mice treated with either intravenous or 
intranasal HA were analyzed by flow cytometry. * p<0.05. 
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Figure 4.3: MTD administration after burn injury leads to pulmonary inflammation marked by 
neutrophil recruitment to the airway. (A) Live cells recovered from BALF of sham mice treated with 
PBS (open bars), sham mice treated with MTD (shaded bars), and burn mice treated with MTD (shaded, 
hatched bars). (B) Live cells recovered from BAL of sham mice treated with PBS (open bars) or burned 
mice treated with MTD (shaded, hatched bars) were analyzed by flow cytometry to quantify neutrophil 
numbers. (C) Protien concentration in BALF, (D) live cells in BALF, and (E) IL-6 in serum of sham mice 
treated with PBS (open bars) or burn mice treated with MTD (shaded, hatched bars). * p < 0.05, ** p < 
0.005, *** p < 0.001.  
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Figure 4.4: mtDNA administration after burn injury does not induce pulmonary inflammation. 
Protein concetration (A) and gated neutrophils (B) in BALF from sham mice treated with PBS (open 
bars) and burn mice treated with mtDNA (shaded, hatched bars).  (A) Protein concentration and (B) live 
cells in BALF from sham mice treated with PBS (open bars) and burn mice treated with unsonicated 
mtDNA and sonicated mtDNA. * p < 0.05. 
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Figure 4.5: Coadministration of HA and mtDNA after burn injury leads to significant increase in 
cellular recruitment to the lung.  Live cells recovered from the BALF of sham mice treated with PBS 
(open bar), burn mice treated with 500 ug/mL HA and 150 ng/mL sonicated mtDNA (hatched bars), 400 
ng/mL sonicated mtDNA (light shaded hatched bars), or 1000 ng/mL sonicated mtDNA (dark shaded 
hatched bars). * p<0.05. 
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CHAPTER 5: CXCL1 DRIVES NEUTROPHIL RECRUITMENT AND ONSET OF ALI 
FOLLOWING ACUTE WOOD SMOKE INHALATION1  
Summary 
Inhalational injury associated with structural fires, wildfires, or explosions leads to acute lung 
injury (ALI) and acute respiratory distress syndrome, for which innovative and faithful animal models are 
needed to develop effective therapeutics.  We have previously reported that damage associated molecular 
patterns (DAMPs) and anti-inflammatory cytokines are correlated with infectious complications in 
patients diagnosed with inhalational injury.  In this report we describe a novel murine model of acute 
inhalational injury that precipitates ALI characterized by an accumulation of protein and neutrophils in 
the airway as well as histological evidence of tissue damage.  This model recapitulates clinically relevant 
phenotypes including susceptibility to opportunistic infection with Pseudomonas aeruginosa, abundance 
of the DAMPs hyaluronic acid and dsDNA, and polarization towards IL-10 early after injury.  Using 
iNOS-/- mice, we found that iNOS is required for increases in IL-10, MCP1, and HA following injury but 
not for protein accumulation, CXCL1 expression and neutrophilia, dsDNA, or infection susceptibility.  In 
agreement with previous studies that established the importance of CXCR2 signaling in inflammation 
following ventilator-induced lung injury, we demonstrated that inhibition of CXCL1 attenuated 
neutrophil recruitment, decreased histopathology scores, and improved bacterial clearance in our model of 
smoke inhalation.  Together these data highlight the importance of differentiating between physiological 
and pathological inflammation after acute smoke exposure and suggest that future studies in patients 
                                                           
1 Attribution: Julia Dunn designed and carried out experiments, analyzed data, created figures, and wrote 
manuscript.  Laurel Kartchner designed and carried out experiments.  Wesley Stepp, Lindsey Glenn and Madison 
Malfitano carried out experiments and analyzed data.  
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should explore the potential therapeutic benefit of attenuating neutrophil recruitment in the first 24h after 
injury.   
Introduction 
Acute smoke inhalation presents a clinical challenge. Acute smoke inhalation resulting from 
structural fires or, increasingly across the western United States, proximity to wildfires, results in severe 
and complex damage to the lung. Inhalational injuries are associated with lengthy and expensive 
hospitalizations, especially when they occur concomitantly with cutaneous burn injury (1). Smoke 
inhalation is often accompanied by cutaneous burns, lacerations, or fractures; in such cases inhalational 
injury is treated last, as it is dwarfed by the immediacy of other traumatic injuries (2).  
The physiological imbalances that result from acute smoke inhalation are not completely 
understood, in large part because a systematic analysis of patient outcomes is complicated by several 
variables that are difficult to control for during outcome analysis. This patient population spans all ages, 
ethnicities, and comorbidities. Moreover, the severity of inhalational injury depends on the smoke source, 
which varies from structure to structure, as well as concentration and duration of exposure. Because 
synthetic materials often burn faster and release more toxics than wood, the types of lung injuries treated 
at trauma centers changes as common construction materials change (2). Different strategies have been 
proposed to diagnose the severity of inhalational injury, ranging from quantification of serum factors to 
measurements of lung function (3-5). Mosier et al emphasize the importance of bronchoscopic analysis 
(visual assessment of the airway) for predicting outcomes; however, these strategies also have significant 
drawbacks and do not uniformly predict outcomes (3).  
A leading cause of mortality following inhalational injury is bacterial pneumonia, which is 
thought to be the result of poor mucociliary clearance combined with impaired immunological 
surveillance(6). Some studies have examined patient bronchoaveolar lavage fluid (BALF) in order to 
characterize the inflammatory state, identify patients at risk for developing pneumonia, and initiate 
antibacterial prophylaxis in high-risk patients. Two damage-associated molecular patterns (DAMPs), 
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dsDNA and hyaluronic acid (HA), are elevated in patients with inhalational injury, especially those who 
subsequently develop bacterial pneumonia (7). Our group has previously shown that IL-10 was elevated 
in patients who develop pulmonary or peripheral bacterial infections and others have observed elevated 
IL-10 in patients who do not survive inhalational injury (5, 8). The prevailing opinion is that trauma leads 
to release of DAMPs that promote an anti-inflammatory phenotype in the lung and contribute to patients’ 
inability to fight opportunistic bacterial infections; however, we have not observed a direct correlation 
between DAMP levels and IL-10 levels in patients. We therefore sough to develop a mouse model of 
inhalational injury to further delineate the relationship between DAMPS and cytokine release. 
Wood smoke inhalation elicits a clinically relevant injury model. A reliable small animal model 
of disease is an invaluable resource for the development of therapeutic interventions. Despite differences 
in magnitude, innate immune responses to stress are largely similar in humans and mice, including 
cytokine and chemokine production as well as leukocyte activation (9). Several studies have utilized 
small (mice, rats) and large (sheep, pigs) animal models to address trauma and acute smoke inhalation, 
primarily using cotton as a source of smoke (10-16). Neutrophil accumulation and activation are 
associated with oxidative tissue damage in an ovine model of cotton smoke inhalation and bacterial 
infection (15). Inhibiting protein oxidation in a mouse model of cotton smoke inhalation with burn injury 
resulted in elevated IL-10 as well as an improvement in lung structure (12). Despite these insights, it is 
necessary to study inhalational injury in a more clinically relevant background due to significant 
disagreement between human clinical findings and results of animal studies (2, 12). We propose that these 
differences are due, in part, to reliance on cotton smoke, because there are differences between injury 
induced by cotton smoke, wood smoke, and plastic smoke (11).  
This study addresses the hypothesis that immune activation early after smoke inhalation leads to 
inflammation and damage to the tissue architecture, which renders the lung vulnerable to bacterial 
challenge.  In this study, we describe a novel murine model of acute exposure to smoke derived from 
plywood, a common building material comprised of wood and adhesives. This model recapitulates many 
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phenotypes previously described in patients diagnosed with an inhalational injury as well as key traits of 
murine acute lung injury. Additionally, we demonstrate the importance of neutrophil recruitment and 
activity as a key determinant of pathology in smoke inhalation and further establish the utility of this 
model for testing interventions that counteract the negative physiological consequences of smoke 
inhalation.  
In this study, we report that exposure to wood smoke leads to the neutrophil accumulation in the 
airway, elevated protein levels of IL-10, MCP-1, and CXCL1/KC, as well as accumulation of DAMPs 
(HA and dsDNA) in the airways and alveoli.  Furthermore, mechanistic studies demonstrate that iNOS 
expression is necessary for elevations in IL-10, MCP-1, and HA but not for changes in CXCL1, 
neutrophil recruitment or the susceptibility to bacterial challenge.  In contrast, CXCL1 neutralization 
results in an approximate 50% decrease in neutrophil recruitment to the airway following injury and 
improved bacterial clearance.  Thus, this study establishes the utility of this model in establishing 
molecular mechanisms that drive this complex injury and highlights its suitability for testing interventions 
that counteract the negative physiological consequences of smoke inhalation. 
Methods 
Mouse housing and care. Female C57BL/6 mice aged 8-10 weeks were purchased from Taconic 
Farms and housed in specific pathogen free facilities. All protocols were approved by the University of 
North Carolina at Chapel Hill’s Institutional Animal Care and Use Committee and were verified to follow 
guidelines from the National Institute of Health concerning use of vertebrate animals in research.  
Smoke inhalation. Mice were anesthetized using tribromoethanol (475mg/kg body weight; 
Sigma-Aldrich) and their dorsum shaved (Fisher NC0854145) prior to injection of subcutaneous 
morphine sulphate (3mg/kg body weight; Westward). Mice were then placed on an intubation platform 
(Penn Century). A catheter (22G x 1”, Exel) was placed in the trachea after visualization with a 
laryngoscope. Mice were then secured to a platform in a supine position and placed in an animal 
induction chamber (Stoelting NC9296517). Plywood sectioned into strips (2.5cm x 8cm, Lowe’s Item 
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#12206 Model # 776391100000) was placed in a side-arm flask on a heat block set to 500°C, causing the 
board to smolder and produce smoke.  ~50g of wood was used at the start of experiments, with additional 
strips added as needed.  Air pumped through the flask forced smoke into the induction chamber for three 
exposures of 2 minutes with a 1 minute break between exposures.  Clear walls of the induction chamber 
allow visual assessment of smoke density –air pressure was kept constant, and the chamber was vented or 
kept sealed in order to maintain smoke density that resulted in visual obstruction at 1-1.5 inches.  The heat 
plate, flask, and induction chamber were set up in a dedicated fume hood.  Mice were resuscitated with an 
intraperitoneal injection of lactated Ringer’s solution (1mL/kg body weight; Baxter Healthcare 
Incorporated), and were given morphine in their drinking water ad libitum for the duration of the 
experiment. Sham mice were treated identically except that air was pumped into the induction chamber 
rather than smoke. Prior to tissue collection, mice were euthanized with gaseous isofluorane. 
Bacterial infection. Pseudomonas aeruginosa (strain PA01) was grown in Luria-Bertani (LB) 
broth at 37°C with shaking to reach mid-log phase growth. Bacterial pellets were washed and 
resuspended with cold PBS with 1% Protease Peptone (PP-PBS) and diluted to 5 x 106 CFU/mL. Serial 
dilutions of inoculum were plated on LB agar to confirm bacterial dosage. 200 uL of inoculum was 
administered to mice via tail vein injection –mock-infected mice received 200uL PP-PBS. Bacterial 
burden in the airway at time of harvest was determined by plating 100uL of broncho-alveolar lavage fluid 
(BALF) in duplicate on LB agar. Bacterial burdens in liver and spleen were determined by plating serial 
dilutions of organ homogenate in PP-PBS on LB agar plates.  
Broncho-alveolar lavage sample acquisition and processing. To collect broncho-alveolar lavage 
fluid (BALF), a catheter (22G x 1”, Exel) was inserted into the trachea and connected to a syringe 
containing 1mL 0.6mM EDTA in PBS. 0.6mL was instilled into the lungs and then withdrawn three times 
to obtain a primary wash.  Typical recovery was 0.75 mL. Two subsequent washes were combined to 
obtain a secondary wash, for which typical recovery was 2 mL. Cell pellets from primary and secondary 
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washes were combined for analysis via flow cytometry or pelleted and stored at -80°C for subsequent 
analysis by qPCR.  
Cell-free supernatant from primary wash was analyzed by Bradford assay and enzyme-linked 
immune-sorbent assay (ELISA) for IL-10, hyaluronic acid, CXCL1, CXCL2 (R&D), IL-12, and MCP-1 
(eBioscience) according to manufacturer’s instructions. Cell-free DNA was enriched from secondary 
BALF. Briefly, 500 µl of BALF supernatant was treated with 50 µl of Proteinase K solution and 125 µl of 
S&P Proteinase K Digestion Buffer (Zymo Research, Irvine, CA). Following proteinase K addition, 
samples were incubated for 30 minutes at 55oC, then 2.7 volumes of S&P DNA binding buffer (Zymo 
Research) were added to each sample. Samples were then mixed and added to Zymo-Spin III-S columns 
for DNA isolation per the manufacturer’s protocol. cfDNA was eluted from the column using 50 µl of 
pre-warmed DNA Elution Buffer (Zymo Research). Total cfDNA per mL of BAL input was determined 
using the Qubit 3.0 fluorimeter (Life Technologies) and the Qubit dsDNA high-sensitivity detection 
reagents (Life Technologies). 
Lungs were removed from mice after BAL extraction. Minced lung tissue was digested in 4 mL 
PBS with 10% Fetal Bovine Serum (PBS-FBS) with 1500 u/mouse collagenase (Worthington) and 0.1 
µg/mouse DNase and shaken at 250rpm at 37°C for 1 h. Samples were filtered through a 100 µm cell 
strainer. Red blood cells were removed with ACK Lysis Buffer and remaining cells were suspended in 
PBS-FBS prior to flow cytometric analysis. Live cells from lung digest and BALF were counted 
manually with a hemocytometer using 0.01% trypan blue cell viability dye (Life Technologies).  
Flow cytometry. Following incubation with Fc Block (eBiosciences), cells were stained with 
labeled antibodies against CD45, CD11b, CD11c, and Ly6G (eBiosciences; BD Biosciences). Cells were 
fixed with 1% paraformaldehyde prior to analysis on a CyAn (Beckmann-Coulter). Samples were 
analyzed with Summit 5.1 software (Beckmann-Coulter). Neutrophils were defined as 
CD45+CD11b+CD11c-Ly6G+, and Macrophages were defined as CD45+CD11c+Ly6G-.  
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Isolation and analysis of gene expression by qRT-PCR. Total RNA was isolated using the 
RNeasy Mini-RNA extraction kit (Qiagen) for BAL cells and the RNeasy Mini-RNA Fibrous Tissue kit 
(Qiagen) for mouse whole lungs. Reverse transcription reactions were performed with the VILO Reverse 
Transcription master mix (Life Technologies) using 0.25 μg of total RNA. Real-time qRT-PCR was 
performed using the QuantStudio 6 (Life Technologies) machine and TaqMan Gene Expression master 
mix (Thermo-Fischer). Each reaction contained 1X TaqMan Gene Expression master mix, cDNA from 40 
ng of RNA, and 1X of gene specific primer/probe combinations (Life Technologies Cat. #4331182; 
Gapdh Primer ID Mm99999915_g1, Tbp Primer ID Mm01277042_m1, IL-10 Primer ID 
Mm01288386_m1, IL-12b Primer ID Mm01288989_m1, MMP8 Primer ID Mm00439509_m1, MMP9 
Primer ID Mm00442991_m1) in a total volume of 20 μl. PCR was performed in duplicate by cycling at 
50oC for 2 min, 95ºC for 15 min, followed by 40 cycles of denaturation at 95ºC for 10 s, and annealing 
and extension at 60ºC for 30 s. Values were derived using the delta-delta cT method comparing sham 
mice to inhalation injury mice at each timepoint. 
Histopathology. To prepare lung tissue for histology, lungs were inflated with 4% 
paraformaldehyde (PFA) in PBS to a constant pressure of 20cmH2O.  Inflated tissue was stored overnight 
in 4% PFA, then rinsed with 70% ethanol.  Left lobes were embedded in paraffin and 4um sections of 
tissue containing large airway branches were taken and stained with hematoxylin and eosin (H&E) at the 
UNC Animal Histopathology Core Facility.  Images of deidentified specimens were taken at the UNC 
Microscopy Services Laboratory using an Olympus BX61 light microscope.  At least 10 non-overlapping 
sections of distal lung tissue (excluding major blood vessels and large airways) were taken per specimen 
using the UPlanFLN 40X/0.75 objective. The UPlanFLN 20X/0.50 objective was used to obtain 
sequential images of a large airway.  Images of the distal lung tissue were scored on a scale of 0 (normal) 
to 2 (maximal) for neutrophil infiltration, proteinaceous debris, and congestion in microvasculature (17). 
Images of large airway sections were scored for the same traits in addition to cytoplasmic vacuolization 
and soughing of airway epithelial cells.  Normalized tissue damage scores were obtained for each 
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specimen by obtaining a weighted value to averaged scores for distal and large airway sections, 
separately, according to the following formula: [(neutrophil score * .25) + (proteinaceous debris * .15) + 
(congestion * .3) + (sloughing + vacuolization * .3)] = Tissue Damage Score.  Reported scores were 
obtained by a single blinded individual, and findings were confirmed by a second blinded individual.  
Patient Samples. Patient BALF was obtained and analyzed as previously described (5). Briefly, 
patients were admitted to the North Carolina Jaycee Burn Center at the University of North Carolina and 
were intubated and on mechanical ventilation for treatment of burn and inhalation injury.  Subjects were 
enrolled over a 2-year period and followed until discharge or death.  Serial bronchial washings from 
clinically-indicated bronchoscopies were collected and analyzed for markers of tissue injury and 
inflammation.  This study was approved by the UNC Biomedical Institutional Review Board.  In this 
analysis we excluded patients who were not diagnosed with inhalational injury and patients for whom HA 
was only measured at days 0 and 1.   
Statistical Analysis. GraphPad Prism Version 5.0 for Windows was used to analyze data by 
Student’s t-Test, One-Way Analysis of Variance (ANOVA) with Tukey post-test, or Two-Way ANOVA 
with Bonferroni post-test, as appropriate.  In cases where data are represented in relation to sham average, 
one-sample t-Test was used to compare values and means to a hypothetical value of 1. Data are 
represented as mean +/- standard error of the mean (SEM).  Statistical significance is indicated as * p < 
0.05, ** p < 0.005, *** p < 0.001.   
Results 
Smoke inhalation causes inflammation in the airway. In mouse models of ALI, an increase in the 
live cell count and protein concentration in the BALF are associated with inflammation and perturbation 
of the alveolar-capillary barrier (17). Therefore, we isolated BALF from sham mice and mice who were 
exposed to plywood smoke, enumerated live cells, and analyzed the total protein content in BALF 
supernatants. Quantification of live cells in the BALF revealed increased cellularity in the airway at 24h, 
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48h, 72h, and 96h following smoke inhalation compared to sham controls (Figure 5.1 A). In the BALF 
supernatants from mice exposed to smoke, we observed an increase in the total protein concentrations, 
especially at 24h and 96h (Figure 5.1 B). Using flow cytometry to characterize cells derived from the 
BALF, we observed an increase in the total number of neutrophils following smoke inhalation compared 
to sham-treated mice (Figure 5.1 C). By contrast, macrophage numbers in the airway were not 
significantly altered by smoke inhalation (Figure 5.1 E). Smoke inhalation did not cause a significant 
increase in the frequency of either neutrophils or macrophages in interstitial lung tissue at 24h, 48h, or 
96h (Figure 5.1 C-D).  
MMP8 (also known as neutrophil collagenase) and MMP9 are produced by activated neutrophils 
to break down connective tissue during leukocyte migration and to promote inflammation by 
proteolytically activating cytokines and chemokines.  RNA expression of MMP8 and MMP9 was 
quantified in cells extracted from BALF by qRT-PCR. We observed an increase in the expression of 
MMP9 but not MMP8 in BALF cells at both 24h and 96h following smoke inhalation compared to sham-
treated mice (Figure 5.1 G). By contrast, smoke inhalation did not cause a change in either MMP8 or 
MMP9 in interstitial lung tissue (data not shown).  To further characterize the activation status of immune 
cells in the BALF, we quantified expression of NOS2 by qRT-PCR.  We observe a 7.35-fold increase 
(p=0.13) in NOS2 expression in smoke-treated mice relative to sham at 24h (Figure 5.1H)   
In order to thoroughly characterize damage to lung tissue, sections of fixed tissue were analyzed 
for five indicators of histopathology, which were normalized to calculate a tissue damage score for both 
distal lung tissue and large airway epithelium (Figure 5.2 A-B). Within 24h of smoke inhalation, we 
observed cytoplasmic vacuolization and sloughing in epithelial cells of the large airways of smoke mice 
(Figure 5.2 G) compared to sham (Figure 5.2 F) as well as hemorrhage and edema in distal lung tissue 
(Figure 5.2 C). Analysis of specimens taken 96h following smoke inhalation indicated an influx of 
neutrophils and macrophages to the distal lung tissue as well as increased congestion of the pulmonary 
microvasculature (Figure 5.2 E,H).  
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Anti-inflammatory cytokines precede HA in the airway. We have previously demonstrated that 
elevated IL-10, a skewed IL-10/IL-12 ratio, and elevations in dsDNA and HA are reliable predictors of 
patient outcomes (5, 7). In mice exposed to plywood smoke, IL-10 is significantly elevated in BALF at 
24h compared to uninjured mice, however the increase is transient and was not significant at subsequent 
time points (Figure 5.3 A). No significant changes in IL-12 protein in BALF were observed at any time 
(data not shown). These data are supported by qRT-PCR, which illustrates an increase in IL10 mRNA in 
cells recovered from the BALF of injured animals normalized to sham average at 24h (Figure 5.3 B). This 
increase is followed by downregulation relative to sham-treated mice between 48h and 96h. By contrast, 
IL-12 mRNA expression was slightly downregulated in BAL cells at 24-48h post-injury and increased at 
72h (data not shown). In interstitial lung tissue, no statistically significant changes in IL-10 gene 
expression were observed at either 24h or 96h. IL-12 gene expression was significantly downregulated in 
lung tissue at 96h following smoke inhalation compared to sham-treated controls (Figure 5.3 B).  
Hyaluronic acid (HA) and cell-free double-stranded DNA (dsDNA) were measured in BALF 
following smoke inhalation or sham procedure. The sham procedure did not change levels of HA or 
dsDNA at any time (Figure 5.3 C-D). dsDNA was elevated in injured mice compared to shams at 12-24h 
before returning to baseline at all subsequent time points (Figure 5.3 C). By contrast, concentrations of 
HA increased over time and reached a peak at 72-96h (Figure 5.3 D). This time-dependent increase in HA 
in the mouse model of inhalational injury mirrors data obtained from patients diagnosed with inhalational 
injury (Figure 5.3 E).  
Systemic infections manifest in the airway of injured mice. Patients diagnosed with inhalational 
injury frequently develop pneumonia following colonization by opportunistic bacteria, most frequently 
Pseudomonas aeruginosa.  We therefore propose that any clinically relevant animal model should render 
mice susceptible to bacterial challenge that does not cause infection in uninjured mice.  In this study, mice 
were exposed to an intravenous inoculation with P. aeruginosa (strain PA01) 48h following smoke 
exposure or sham treatment.  We quantified bacterial recovery from BALF at 24h, 48h, and 96h following 
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infection (Figure 5.4 A). No bacteria were recovered from BALF of sham mice after intravenous 
inoculation with P. aeruginoasa strain PA01.  When mice were inoculated with PA01 48h after smoke 
inhalation, bacteria were recovered from BALF at 24h, 48h, and 96h after inoculation. Bacterial recovery 
from liver and spleen tissue was sporadic and unaltered by injury status (data not shown). Infection 
augmented concentrations of protein and HA in the BALF of injured mice (Figure 5.4 B-C).  
iNOS deficiency reverses cytokine and chemokine upregulation but not injury severity. iNOS 
upregulation in lung tissue has been observed in other models of acute smoke inhalation (13, 16), and 
iNOS activity is known to modulate neutrophil recruitment and activation as well as cytokine and 
chemokine production (18).  We therefore designed a series of experiments to determine the impact of 
iNOS expression on inflammation following acute smoke inhalation.  iNOS-/- mice on a C57BL/6 
background were bred in-house alongside WT control mice. We did not observe a change in protein 
accumulation in the BALF of iNOS-/- mice following smoke inhalation at either 24h (data not shown) or 
96h following smoke inhalation or sham procedure (Figure 5.5 A). Similarly, iNOS deficiency did not 
significantly alter neutrophil numbers in the BALF at 24h (data not shown) or 96h following injury 
(Figure 5.5 B).  
While IL-10 and MCP-1 were elevated in BALF 24h following smoke inhalation in WT mice, a 
similar increase was absent in iNOS-/- animals (Figure 5.5 C-D). The smoke-dependent increase in HA 
concentration in BALF at 96h was also attenuated in iNOS-/- animals, however concentrations of dsDNA 
were not altered in iNOS-/- mice compared to WT controls (Figure 5.5 E-F). WT and iNOS-/- mice were 
inoculated via tail vein injection with 1x10^6 CFU PA01 at 48 h following injury or control procedure, 
and CFU recovery from BAL was measured 48h later. We did not observe an iNOS-dependent difference 
in bacterial clearance following an intravenous challenge (data not shown). CXCL1 drives neutrophil 
recruitment to the airway following smoke exposure. In order to delineate potential chemotactic signals 
responsible for neutrophil recruitment to the airway following smoke inhalation, we measured the 
neutrophil chemoattractants CXCL1 (also known as KC) and CXCL2 in BALF.  At 24h post-injury we 
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observed an increase in CXCL1 in BALF; however, CXCL1 concentrations returned to baseline at all 
subsequent time points (Figure 5.6 A). We did not detect CXCL2 in injured mice at any time following 
injury (data not shown). 
To determine whether CXCL1 was responsible for neutrophil recruitment to the airway following 
inhalational injury, we intravenously administered a neutralizing antibody against CXCL1 or isotype 
control immediately after smoke or sham procedure and at 24h. We observed a significant decrease in 
total neutrophil numbers in the airway at 24h, 48h and 72h compared to smoke-treated mice given an 
isotype control antibody (Figure 5.6 B). Increased concentration of neutralizing antibody did not alter 
neutrophil numbers (data not shown), suggesting that another chemotactic signal contributes to neutrophil 
recruitment, especially at 72-96h.  We quantified histopathology at 24h in mice treated with neutralizing 
antibody or isotype control and observed a significant decrease in tissue damage scores in distal airway 
specimens (Figure 5.6 C).  This decrease was primarily attributable to a decrease in congestion scores 
(0.930.11 vs. 0.270.28; p<0.05). 
To test whether attenuated neutrophil recruitment impacted sensitivity to bacterial infection in the 
lung following intravenous inoculation, we infected anti-CXCL1 and isotype treated mice at 48h 
following injury with 1x10^6 CFU PA01 and quantified CFUs, protein, neutrophils, and HA in BAL at 
48h following infection (Figure 5.7 A).  Significantly less bacteria were recovered from the airway of 
mice treated with a neutralizing antibody prior to infection (Figure 5.7 D). Following infection, 
recruitment of neutrophils to the airway was unaltered by early administration of anti-CXCL1, however 
HA in the airway was decreased in these mice (Figure 5.7 C-D). Administration of neutralizing antibody 
did not alter protein recovery from the airway in either uninfected or infected mice (Figure 5.7 E).    
Discussion 
Inhalation of plywood smoke yields a clinically relevant phenotype. Acute smoke inhalation 
presents a significant clinical challenge for survivors of structural fires, inhabitants of regions at risk for 
wildfires, first responders, and members of the armed forces.  Inhalational injury is among a spectrum of 
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stimuli that can precipitate acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). 
Despite significant research into targeted therapies for ALI/ARDS, an effective pharmaceutical 
intervention does not currently exist (19). Inhalational injury and ALI are not uniform diseases –they are 
brought on by a multitude of stimuli and their outcomes are impacted by comorbidities from 
inflammatory disorders to smoker status (17, 19-21). It is therefore critical that future research into 
inhalational injury and ALI accounts for these complexities.  Clinical research can make use of resources 
available through the Precision Medicine Initiative (PMI), and animal studies should be designed to 
replicate, as faithfully as possible, the etiology of human disease.   
Herein we report the development of a mouse model of acute exposure to smoke derived from 
plywood, a common building material.  This model recapitulates many of the phenotypes previously 
reported to predict outcomes in patients, including a predominance of neutrophils in the airway, 
polarization towards IL-10 production, and elevated dsDNA and HA within 72h of the injury (5, 7, 22). It 
has previously been reported that macrophage numbers in the airway do not change between the acute 
phase of ARDS and resolution; however, neutrophil numbers are subject to change based on disease state 
(22). We observed a similar phenotype in our model of acute exposure to plywood smoke. Specifically, 
we demonstrated that macrophage numbers in BALF are unaltered by the injury, while the number of 
neutrophils increases following smoke inhalation (Figure 1C-F).  
Because pneumonia poses a significant challenge to patient recovery, it is critical that any animal 
model faithfully recapitulate susceptibility to opportunistic infection. In this injury model, mice exposed 
to smoke from plywood are susceptible to infection following a systemic bacterial challenge.  Infection is 
restricted to the airway and is not detectable in the liver or the spleen. 
Importantly, because of the challenges inherent in clinical research regarding the timing and 
frequency of sample acquisition, this model clarifies the dynamic relationship between DAMPs and anti-
inflammatory cytokines in the injured lung.  Prevailing wisdom is that tissue damage leads to DAMP 
release, and detection of DAMPs through scavenger receptors and other pattern recognition receptors 
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triggers an anti-inflammatory signaling cascade to limit further damage due to immunopathology.  Data 
from this model echo published clinical data, which suggests that anti-inflammatory cytokine production 
occurs rapidly in the lung following injury in an attempt to minimize inflammation that would 
compromise gas exchange across the alveolar-capillary barrier.  
iNOS drives inflammation but not outcomes after inhalational injury. It has been reported that a 
murine model of cotton smoke inhalation with and without burn injury led to an increase in iNOS 
expression and activity in the airway (13), and iNOS is expressed in macrophages and airway epithelial 
cells following sepsis (23).  We interrogated the inflammatory response to acute smoke inhalation in mice 
deficient for iNOS and observed that, in the absence of iNOS, many relevant injury phenotypes are 
absent. Notably, iNOS deficiency prevents smoke-induced elevation of IL-10 and MCP-1 at 24h, as well 
as release of HA into the airway at 96h. These changes did not, however impact neutrophil recruitment or 
damage to the alveolar-capillary barrier.  Moreover, in support of other studies which have demonstrated 
that iNOS expression and activity is dispensable for clearance of P. aeruginosa infection, we do not 
observe any change in bacterial clearance in injured mice deficient for iNOS (24).   
This result is significant in that it illustrates the distinction between inflammation, 
immunopathology, and protective immunity.  Until now, it has been impossible to differentiate between 
correlative and causative relationships.  Previously, both IL-10 and dsDNA have been correlated with the 
onset of infection, however data using iNOS-/- mice alongside WT counterparts indicate that dsDNA can 
be elevated without a concomitant increase in IL-10 and that these changes do not alter the outcomes 
following bacterial challenge.   These data indicate that it may be possible, using translationally relevant 
models, to uncouple clinical phenotypes from outcomes and therefore identify the most effective 
intervention strategies.   
CXCL1 signaling drives outcomes after smoke inhalation. Significant clinical data exists 
suggesting that expression of the potent neutrophil chemoattractant IL-8 is elevated following trauma and 
that its activity is a key determinant of outcomes (8, 25). A spike in IL-8 is observed in patient serum 
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following burn injury in the absence of sepsis (25). In a study of inhalational injury, IL-8 was elevated in 
survivors compared to those who succumbed to the injury (8).  
In an animal model, inhibition of the murine IL-8 homologue CXCL1 (also known as KC) 
secretion into the serum following burn correlated with a decrease in several markers of lung injury (26). 
Here we show that intravenous administration of a neutralizing antibody against CXCL1 attenuates 
neutrophil recruitment to the airway. Although this did not significantly impact the injury phenotype as 
assessed by concentration of protein and HA in BALF, it did render the mice less susceptible to infection. 
Following infection, neutrophil recruitment to the airway was equivalent in mice treated with neutralizing 
antibody compared to isotype control, indicating that mice maintained the ability to mount a protective 
immune response. This result highlights an important objective in modulating the immune response to 
trauma; specifically, to reduce pathogenic inflammation without paralyzing the immune response and 
increasing vulnerability to infection.  
Future studies to determine how inhalation becomes inflammation. Because inhibition of CXCL1 
signaling did not completely deter neutrophil recruitment and CXCL2 was not detectable after smoke 
inhalation, it would be beneficial to characterize the role of LTB4 in neutrophil recruitment. Furthermore, 
we hypothesize that airway epithelial cells produce CXCL1 following smoke exposure, and studies are 
underway to test this hypothesis and to determine the molecular signals that trigger release of CXCL1.  
Changes in expression of TLR on immune cells following burn injury have been described 
previously (27-29). TLR signaling is upregulated in trauma patients (30) and is critical for survival in 
Pseudomonas-induced ALI (31). Signaling via TLR-TRIF-NFkB in myeloid cells promotes ALI in an 
acid aspiration model by promoting pathogenic inflammation following detection of oxidized lipids (32). 
Future studies in our model of acute exposure to plywood smoke will therefore be focused on determining 
the effect of smoke inhalation on TLR4 expression and the role of TLR4 signaling in inflammation 
following injury and susceptibility to pneumonia.   
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FIGURES 
 
Figure 5.1: Experimental model of smoke exposure. Mice exposed to smoke from particle board were 
analyzed for evidence of acute lung injury (ALI) and for bacterial control after systemic inoculation.    
 90 
 
Figure 5.2: Neutrophilic inflammation following acute wood smoke inhalation.  (A) Total live cells 
were enumerated in BALF at indicated time points following smoke or sham procedure. (B) Protein 
concentration in BALF cell-free supernatant was measured by Bradford assay. (C-D) Neutrophils and (E-
F) macrophages were quantified by flow cytometry and normalized to live cell counts in BAL and whole 
lung following injury. (G) MMP8 and (H) MMP9 expression in BAL cells and whole lung tissue 
normalized to sham average at 24h and 96h after injury. Data were analyzed by two-way ANOVA with 
Bonferroni post-test and significance is indicated as * p < 0.05, ** p < 0.005, *** p < 0.001. 
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Figure 5.3: Histological evidence of lung injury following acute smoke exposure.  Sections of lung 
tissue were analyzed by histology and scored by blinded individuals. (A) Tissue injury score in sections 
of distal lung tissue sections (A) and large airway sections (B) in pooled sham mice and smoke treated 
mice at two time points.  p-value represents Tukey post-test following a one-way ANOVA.  
Representative images of sham distal lung tissue (C) and large airway (F) are shown, as well as smoke-
treated distal lung tissue (D, 24h; E, 96h) and large airway (G, 24h; H, 96h). Scale bars correspond to 
50um. Data were analyzed by one-way ANOVA with Tukey post-test and significance is indicated by *** 
p < 0.001. 
 
  
Sham 24h 96h
0.00
0.25
0.50
L
u
n
g
 I
n
ju
ry
 S
c
o
re
Distal Lung Tissue Score
p = .077
Sham 24h 96h
0.0
0.5
1.0
1.5
L
u
n
g
 I
n
ju
ry
 S
c
o
re
Large Airway Score
***
A B
 92 
 
 
Figure 5.4: Temporal regulation of IL-10 and DAMP release following smoke inhalation.  (A) IL-10 
concentration in primary BALF cell-free supernatant following inhalational injury, normalized to sham 
average concentrations at each time point. (B) IL-10 expression in BALF cells and IL-10 and IL-12 
expression in interstitial lung tissue normalized to sham average at indicated time points after injury, 
normalized to sham average expression at each time. (C) cfDNA concentration in secondary BALF 
supernatant. (D) Hyaluronic acid concentration in primary BALF supernatant following inhalational 
injury.  (E) Hyaluronic acid concentration in BALF samples from patients diagnosed with inhalational 
injury. Data were analyzed by Student’s T-test or two-way ANOVA with Bonferroni post-test, as 
appropriate, and significance was indicated by * p < 0.05, *** p < 0.001.  
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Figure 5.5: Pneumonia develops subsequent to systemic infection in mice following smoke 
inhalation.  (A)  CFU recovery from BAL of mice infected with 1x106 CFU PA01 at 48h after sham or 
smoke procedure and harvested at various timepoints following infection. (B) Protein concentration and 
(C) Hyaluronic acid concentration in BAL cell-free supernatant of mice infected with 1x106 CFU PA01 at 
48h after sham or smoke procedure and harvested 48h after infection. Data were analyzed by Student’s T-
test between treatment groups at each time-point and significance is indicated by * p < 0.05. 
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Figure 5.6: iNOS deficiency prevents cytokine production but not inflammation after smoke 
inhalation. (A) Protein concentration in BALF at 96h following sham or injury procedure. (B) 
Neutrophils quantified by flow cytometry and normalized to live cell counts in BAL at 96h following 
injury. (C) IL-10 and (D) MCP-1 concentration in BALF at 24h following sham or injury procedure. (E) 
Hyaluronic acid concentration in BALF at 96h following sham or smoke procedure. (F) cfDNA 
concentration in BALF 24h after sham or smoke treatment. Data were analyzed by two-way ANOVA 
with Bonferroni post-test and significance is indicated by * p < 0.05, *** p < 0.001.  
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Figure 5.7: CXCL1 drives neutrophilia following smoke exposure.   (A) CXCL1 concentration in 
BALF at 1-4 days following sham or smoke procedure. (B)  Mice were treated with anti-CXCL1 or 
isotype control at 0h and 24h following injury. Neutrophils were quantified by flow cytometry and 
normalized to live cell counts in BAL at 24h and 48h following injury. (C) Tissue injury scores from 
distal airway sections of smoke-treated mice who received anti-CXCL1 or isotype control and harvested 
24h later. Data were analyzed by Student’s T-test (A,C) and two-way ANOVA (B) and significance are 
represented as * p < 0.05.  
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Figure 5.8: Early inhibition of neutrophil migration protects against infection and HA release. (A) 
Experimental design. Mice were treated with anti-CXCL1 or isotype control antibody via tail-vein 
injection at 0h and 24h following smoke exposure. At 48h mice were inoculated with PA01 or vehicle 
control via tail vein injection. Samples were collected at 48h following infection, 96h following injury. 
(B) CFU recovery from BAL of smoke-treated mice treated with anti-CXCL1 or isotype control prior to 
infection with PA01.  (C) Neutrophils from BALF quantified by flow cytometry and (D) hyaluronic acid 
concentration in BALF following smoke and infection in mice treated with anti-CXCL1 or isotype 
control. (D) Protein concentration in BALF of infected vs. uninfected mice treated with anti-CXCL1 or 
isotype control. Data were analyzed by Student’s T-test and significance is indicated by * p < 0.05, *** p 
< 0.001.  
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CHAPTER 6: NOX2 ACTIVITY PROMOTES RESOLUTION OF INFLAMMATION 
AFTER ACUTE WOOD SMOKE INHALATION.1 
Summary 
Reactive oxygen species (ROS) potently induce tissue damage during inflammation, and 
antioxidant administration has been used extensively in animal studies of smoke inhalation to attenuate 
pathology; however, activity of granulocyte NADPH oxidase (NOX2) triggers anti-inflammatory, pro-
resolution pathways that offset oxidative tissue damage.  In this study, we set out to determine whether 
NOX2-dependent anti-inflammatory signals played a role in the onset and resolution of inflammation 
following acute smoke exposure.  Protein concentration and neutrophil recruitment to the lung were 
significantly aggravated in NOX-2 deficient (CGD) mice after smoke exposure.  Increased neutrophil 
recruitment may be attributable to increased production of neutrophil chemoattractants, CXCL1 and 
LTB4, in CGD mice compared to WT controls.  Finally, we tested one established mechanism by which 
NOX2 activity promotes anti-inflammatory signaling, specifically stabilization of HIF1, by treating 
mice with dimethyloxalylglycine (DMOG) to activate HIF1 in vivo.  Although DMOG treatment did not 
reverse the hyper-inflammatory state of CGD mice after smoke inhalation, it did attenuate inflammation 
in WT mice.  The data presented herein clearly establish a role for NOX2 activity in promoting resolution 
of inflammation after smoke inhalation.  
Introduction 
Oxidative tissue damage has been identified as a key determinant of inflammation and outcomes 
following smoke inhalation and burn injury (1-3). Formation of carbonyl adducts on proteins in the 
                                                           
1 Attribution: Julia Dunn performed all of the experiments, analyzed data, and prepared graphs.  Madison Malfitano, 
Laurel Kartchner, and Lindsey Glenn performed smoke inhalation experiments.  
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presence of reactive oxygen species (ROS) interferes with enzymatic function, leading to changes in 
metabolic activity and ultimately cell death (4). Carbonylated proteins have been observed in animal 
models of smoke inhalation and burn injury (3). Protein carbonylation was inhibited in a sheep burn and 
smoke inhalation model by administration of H2S, a molecule that scavenges peroxynitrite, and this was 
associated with decreased tissue damage and an increase in IL-10 expression (3).  
In vivo ROS are scavenged by antioxidants derived from Vitamin E, specifically - and -
tocopherol (aT and gT), with gT additionally able to scavenge peroxynitrite (5). Physiological 
concentrations of aT were depleted in a sheep model of burn and smoke inhalation; administration of 
Vitamin E  replenished aT concentrations and resulted in decreased inflammation and improved lung 
function (6). Administration of gT blocked increases in lung tissue and serum concentrations of IL-8 and 
IL-6, suggesting a direct connection between oxidative stress and pro-inflammatory cytokine release (7).  
Although several molecular mechanisms are capable of producing extracellular ROS after injury 
or infection, recruitment and activation of neutrophils has been identified as a key determinant of 
oxidative tissue damage in inhalational injury (2, 3). Granulocyte NADPH oxidase (NOX2) is a potent 
source of ROS in neutrophils, macrophages, and eosinophils. During recruitment, integrin ligation causes 
several biological changes in neutrophils, some of which promote actin remodeling to allow 
transmigration and chemotaxis, while others initiate a cascade that enables subsequent NOX2 activation 
(8, 9). gp91phox is a transmembrane protein and is the main scaffolding subunit of the NOX2 machinery 
that resides in the plasma membrane.  Folding of the plasma membrane during phagocytosis and 
subsequent recruitment of the remaining subunits result in active NOX2 that pumps superoxide into 
phagocytic vesicles to destroy microbes or debris (10). Assembly of the NOX2 machinery at the 
cytoplasmic membrane results in extracellular ROS.  Despite the ability of NOX2-derived ROS to induce 
oxidative tissue damage, an ever-growing body of evidence suggests that NOX2 activity is indispensable 
for promoting resolution of inflammation (11-16).  
 102 
Rather than relieving tissue damage due to oxidative stress, NOX2 deficiency prevents the 
resolution of inflammation through a variety of mechanisms (12-16). Chronic granulomatous disease 
(CGD) is an inflammatory disease caused by deficient NOX2 activity attributable to mutations in any of 
the enzyme’s subunits.  Patients exhibit failure to resolve inflammation following infection, resulting in 
the formation of granulomas.  Several knockout models of CGD have been described in mice, the most 
common of which are gp91phox-/- and gp47phox-/-.  Deficient NOX2 signaling causes activation of 
NFkB and production of TNFa, IL-17, and G-CSF in macrophages (17).  Moreover, NOX2 activity 
promotes translocation of Nrf2 to the nucleus within the first 4 hours of inflammation, leading to 
transcription of genes that suppress inflammation and reverse oxidative stress(16).  
Neutrophils in CGD mice exhibit delayed induction of apoptosis as well as failure to modify PS 
to lyso-PS, which led to suppressed clearance through efferocytosis, and failure to resolve inflammation 
(14, 15). Characterization of neutrophils from CGD patients illuminated a role of mitochondrial-derived 
ROS in NET formation, and furthermore indicate an increased incidence of spontaneous NETosis (11). In 
these models of injury or infection, studies of CGD mice have illuminated the varied roles of NOX2 in 
promoting resolution of inflammation that can be amplified in WT mice. 
In this study we characterized the role of NOX2 activity in the onset and resolution of 
inflammation in a clinically relevant murine model of acute smoke inhalation.  We observed that 
accumulation of neutrophils, protein concentration, and the chemokine KC in BALF are elevated in CGD 
mice. We have previously reported elevations in IL-10, MCP1, and dsDNA at 24h after inhalational 
injury as well as HA at 72-96h after injury.  This study indicates that these phenotypes are independent of 
NOX2 activity because they are not significantly altered in CGD mice. Finally, we show that stabilization 
of HIF1a with DMOG, which reversed the hyperinflammatory state of CGD mice in an intestinal damage 
model, did not substantially improve inflammation in CGD mice but did attenuate neutrophilia and HA 
release in WT mice.  Together, these results point to an important role for NOX2 in resolving 
inflammation after smoke inhalation. 
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Methods 
Mice.  Homozygous gp91phox-/- (CGD) mice were bred in-house alongside WT controls, and 
raised in a specific pathogen free facility until 9-11 weeks of age.  All experiments were designed and 
conducted in accordance with the National Institutes of Health regulations governing the treatment of 
vertebrate animals in biomedical research, and protocols were approved by the Institutional Animal Care 
and Use Committee (IACUC) at the University of North Carolina at Chapel Hill.   
Smoke inhalation. Mice were exposed to 6 total minutes of smoke generated from combusted 
plywood as previously described.  Briefly, mice anesthetized with tribromoethanol (475mg/kg body 
weight; Sigma-Aldrich) and treated with subcutaneous morphine sulphate (3mg/kg body weight; 
Westward) were intubated and secured to a platform in a supine position, then placed in an animal 
induction chamber (Stoelting NC9296517). Plywood sectioned into strips (2.5cm x 8cm, Lowe’s Item 
#12206 Model # 776391100000) was heated in a 2L side-arm flask to generate smoke.  Air pumped 
through the flask forced smoke into the induction chamber for three exposures of 2 minutes with a 1 
minute break between exposures. Mice were resuscitated with an intraperitoneal injection of lactated 
Ringer’s solution (1mL/kg body weight; Baxter Healthcare Incorporated), and were given morphine in 
their drinking water ad libitum for the duration of the experiment. Sham mice were treated identically 
except that air was pumped into the induction chamber rather than smoke. Dimethyloxalylglycine 
(DMOG) was resuspended to 4 mg/mL in PBS, and 100 uL of DMOG or vehicle control was 
administered via intraperitoneal injection immediately after smoke exposure and each day until 
euthanasia. Prior to tissue collection, mice were euthanized with gaseous isofluorane. 
Broncho-alveolar lavage sample acquisition and processing. To collect broncho-alveolar lavage 
fluid (BALF), a catheter (22G x 1”, Exel) was inserted into the trachea and connected to a syringe 
containing 1mL 0.6mM EDTA in PBS. 0.6mL was instilled into the lungs and then withdrawn three times 
to obtain a primary wash –typical recovery was 0.75 mL. Two subsequent washes were combined to 
obtain a secondary wash, for which typical recovery was 2 mL. Cell pellets from primary and secondary 
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washes were combined for analysis via flow cytometry.  Cell-free supernatant from primary wash was 
analyzed by Bradford assay and enzyme-linked immune-sorbent assay (ELISA) for IL-10, hyaluronic 
acid, CXCL1 (R&D), and MCP-1 (eBioscience) according to manufacturer’s instructions.  LTB4 activity 
was quantified in primary BALF using a parameter assay kit (R&D).  Cell-free DNA was enriched from 
500uL of secondary BALF using a cfDNA enrichment kit (Zymo Research). Total cfDNA per mL of 
BALF was determined using the Qubit 3.0 fluorimeter (Life Technologies) and the Qubit dsDNA high-
sensitivity detection reagents (Life Technologies). 
Lungs were removed from mice after BAL extraction. Minced lung tissue was digested in 4 mL 
PBS with 10% Fetal Bovine Serum (PBS-FBS) with 1500 u/mouse collagenase (Worthington) and 0.1 
µg/mouse DNase and shaken at 250rpm at 37°C for 1 h. Samples were filtered through a 100 µm cell 
strainer. Red blood cells were removed with ACK Lysis Buffer and remaining cells were suspended in 
PBS-FBS prior to flow cytometric analysis. Live cells from lung digest and BALF were counted 
manually with a hemocytometer using trypan blue dye.  
Flow cytometry. Following incubation with Fc Block (eBiosciences), cells were stained with 
labeled antibodies against CD45, CD11b, CD11c, and Ly6G (eBiosciences; BD Biosciences). Cells were 
fixed with 1% paraformaldehyde prior to analysis on a CyAn (Beckmann-Coulter). To quantify RONS 
production, stained cells were incubated with 0.75 mg Dihydrorhodamine 123 (DHR; Thermo-Fischer; 
Waltham, MA).  Duplicate samples were either stimulated with 62.5 ng phorbol 12-myristate 13-acetate 
(PMA) or left unstimulated.  After 30 min, reactions were quenched with a fixation buffer containing 1% 
paraformaldehyde and mean fluorescence intensity (MFI) was measured.  Samples were analyzed with 
Summit 5.1 software (Beckmann-Coulter). Neutrophils were defined as CD45+CD11b+CD11c-Ly6G+, 
and Macrophages were defined as CD45+CD11c+Ly6G-.  
Statistical Analysis. GraphPad Prism Version 5.0 for Windows was used to analyze data by 
Student’s t-Test, One-Way Analysis of Variance (ANOVA) with Tukey post-test, or Two-Way ANOVA 
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with Bonferroni post-test, as appropriate. Data are represented as mean +/- standard error of the mean 
(SEM).  Statistical significance is indicated as * p < 0.05.   
Results 
NOX2 deficiency amplifies inflammation after acute smoke inhalation. Production of ROS by 
neutrophils has the potential to induce oxidative tissue damage and to initiate pro-resolution signaling 
pathways.  To differentiate between these mechanisms, we measured production of ROS and RNS by 
neutrophils in WT mice after smoke inhalation and also quantified inflammation in CGD mice compared 
to WT controls in our smoke inhalation model.  We do not observe a significant increase in intracellular 
oxidation of Dihydrorhodamine 123 by neutrophils recovered from the BALF at 24h, 48h, or 96h after 
smoke inhalation, indicating that on a per-cell basis neutrophils do not exhibit an increase in reactive 
oxygen and nitrogen species (RONS) production (Figure 6.1 A). We observed a significant increase in 
protein and neutrophils in BALF of CGD mice with and without smoke inhalation injury compared to 
WT controls (Figure 6.1 B-C).  In interstitial tissue, we observe an increase in neutrophil count after 
smoke inhalation in WT mice, however in CGD mice neutrophil numbers in interstitial lung tissue are 
elevated regardless of injury status compared to WT sham levels (Figure 6.1 D).   
NOX2 deficiency is known to interfere with neutrophil clearance by blocking apoptosis and 
preventing recognition of apoptotic neutrophilx by macrophages (16).  We therefore set out to determine 
whether the increased number of neutrophils observed in BALF of CGD mice after smoke inhalation was 
due to neutrophils failing to undergo apoptosis or an accumulation of apoptotic neutrophils that had yet to 
progress to secondary necrosis.  We measured expression of Annexin V and internalization of 7-AAD in 
BALF cells form WT and CGD mice after smoke inhalation.  In samples from WT mice after smoke 
inhalation we did not observe a change in the fraction of apoptotic neutrophils, however there was a 
decrease in the fraction of neutrophils undergoing secondary necrosis (Figure 6.1 E).  In CGD mice, we 
observe a greater fraction of apoptotic neutrophils than in WT mice, with and without smoke inhalation, 
and a vanishingly small fraction of neutrophils undergoing secondary apoptosis.   
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Leukotriene B4 (LTB4) is a potent neutrophil chemoattractant whose activity is lost when it is 
oxidized (18).  We therefore measured LTB4 activity in BALF supernatants from sham and smoke-
treated WT and CGD mice using a competition assay.  In WT mice we did not observe depletion in 
fluorescent signal from 100% after sham treatment, indicating absence of active LTB4. Similarly, we do 
not observe an increase in LTB4 activity after smoke inhalation in WT mice (Figure 6.1 F).  By contrast, 
we observe a significant increase in LTB4 activity in smoke-treated CGD mice compared to WT.   
NOX2 drives cytokine production but not DAMP release after smoke inhalation. We have 
previously reported an increase in IL-10, MCP1, and dsDNA in BALF at 24h following smoke inhalation 
and accumulation of HA at 72-96h after injury.  At 24h after injury, we do not observe an increase in 
either IL-10 or MCP1 in CGD mice, however dsDNA concentrations were comparable in smoke treated 
CGD mice compared to WT (Figure 6.2 A-C).  We observed an increase in dsDNA concentrations in 
uninjured CGD mice compared to WT, however there was also an injury-dependent increase in dsDNA.  
In contrast, there was no change in HA concentrations in CGD mice compared to WT 96h after sham or 
smoke treatment (Figure 6.3 D).  
HIF1 stabilization attenuates smoke-dependent inflammation in WT but not CGD mice. 
Previous reports illustrated a role for HIF1 in resolving intestinal inflammation in WT mice and 
demonstrated that this mechanism was interrupted in CGD mice (19). We set out to determine whether 
pharmacological stabilization of HIF1 would exert a similar anti-inflammatory effect after acute smoke 
inhalation in WT and CGD mice using dimethyloxalylglycine (DMOG) administration, which increases 
HIF1 expression in vivo (20). In CGD mice 96h after inhalation, DMOG treatment did not change 
concentrations of protein or HA in the BALF compared to vehicle control (Figure 6.3 A-B).  96h after 
injury, DMOG treatment resulted in a decrease in CXCL1 concentration in BALF of CGD mice 
compared to vehicle control at 96h after injury; however, we observed a significant increase in neutrophil 
numbers in CGD mice treated with DMOG compared to vehicle controls (Figure 6.3 C-D).  In WT mice, 
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DMOG administration led to a significant decrease in neutrophil recruitment and HA concentration in the 
BALF at 96h after injury (Figure 6.3 B-C).  
Discussion 
Several reports have illustrated the importance of NOX2 in resolution of inflammation by 
demonstrating that injuries and infections involving neutrophil recruitment result in aggravated damage in 
mice deficient for NOX2 (12-16, 19). These studies have highlighted important downstream targets of 
neutrophil-derived ROS in promoting resolution.  In this study, we set out to determine if NOX2 
deficiency would exert a similar pro-inflammatory effect after acute smoke inhalation. We observe 
substantial amplification of protein concentration and neutrophil recruitment in the BALF after smoke 
inhalation in CGD mice.   
Increased neutrophilia may be attributable to elevated LTB4 activity and production of the 
neutrophil chemoattractant CXCL1 (also known as KC).  Following a fungal infection, acute induction of 
CXCL1 mRNA expression occurred in both WT and CGD mice, however CXCL1 production was 
sustained for up to a week only in CGD mice (12). We similarly observed CXCL1 protein expression in 
WT mice has returned to baseline by 48h after smoke exposure; however, CXCL1 remains elevated in 
BALF of CGD mice at 96h.  Furthermore, LTB4 activity after smoke exposure is significantly elevated in 
CGD mice compared to WT controls, suggesting that LTB4 oxidation may limit inflammation in WT 
mice.  Sustained CXCL1 expression and LTB4 activity may account for increased neutrophilia after 
smoke exposure in CGD mice.    
Antioxidant treatment after burn and cotton smoke inhalation has been shown to promote 
increased IL-10 and improved lung function (3). In a mouse model of intra-tracheal LPS administration, 
no change in IL-10 expression was observed in CGD mice (13). Here we show that in CGD mice IL-10 
was not increased compared to sham controls after acute smoke inhalation.  This result, in context of data 
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in the literature, suggests that NOX2 activity promotes IL-10 production through intracellular 
mechanisms that are not impacted by administration of antioxidants.  
Although NOX2 activity is known to promote NET formation in neutrophils, in CGD neutrophils 
mitochondrial ROS is sufficient to induce NET formation and oxidation of extruded DNA (11).  
Moreover, neutrophils from CGD patients exhibit spontaneous ex vivo NETosis accompanied by an 
increase in MPO:DNA complexes in patient serum (11). Spontaneous NETosis may account for the 
increased cfDNA observed in BALF of CGD mice; future studies can confirm this hypothesis by 
quantifying relative amplification of the 16S mtDNA by PCR compared to 18S genomic DNA.  
Based on published studies demonstrating the ability of pharmacological HIF1 stabilization to 
reduce inflammation in WT mice and reverse the hyperinflammatory state in CGD mice after intestinal 
damage, we expected to observe similar results in our model (19). Although we did not observe improved 
inflammatory readouts in CGD mice treated with DMOG, we did observe decreased neutrophil numbers 
and HA concentration in WT mice treated with DMOG after smoke inhalation compared to PBS-
treatment.  
These results suggest that although HIF1 plays a protective role in the lung after smoke 
inhalation, the connection between NOX2 activity and HIF1 stabilization may not be as direct as it was 
observed in another injury model.  Future studies will continue to explore potential mechanisms for 
increased inflammation in CGD mice after smoke inhalation, in order to identify strategies for 
suppressing inflammation in CGD and WT mice.  Although antioxidant administration may offset the 
negative effects of tissue oxidation during inflammation, this solution does not address oxidant-sensitive 
pro-resolution pathways that would also be suppressed.  Such targets of NOX2 signaling include Nrf2, 
Ref1, and NFkB (17).  Agonizing one or more of these targets, along with antioxidant administration to 
protect the lung against oxidative stress, may represent a viable option for the treatment of inhalational 
injury.   
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FIGURES 
 
Figure 6.1: NOX2 deficiency amplifies inflammation after acute smoke inhalation. (A) Production of 
RO/NS in neutrophils isolated from BALF of sham (open bars) or smoke inhalation (shaded bars) treated 
mice was determined as fluorescence of DHR123 measured by flow cytometry.  Stimulation index was 
calculated as MFI of PMA stimulated cells divided by the MFI of unstimulated cells. (B) Protein 
concentration in BALF of sham (open bars) and smoke (shaded bars) treated WT and CGD mice 96h after 
treatment. (C-D) Neutrophils were quantified by flow cytometry in BALF (C) and whole lung digest (D) 
as a percentage of live cells and normalized to total cell counts. (E) Samples prepared for flow cytometry 
from BALF were stained with PE-conjugated Annexin V and 7-AAD to quantify apoptotic 
(AnnexinV+7AAD-) and secondary necrotic (AnnexinV+7AAD+) cells within the gated neutrophil 
population.  (F) LTB4 activity was quantified in BALF using a competition-based assay and results are 
represented as % signal compared to negative control. Data were analyzed by two-way ANOVA with 
Bonferroni post-test and significance denoted as *p < 0.05. 3-4 sham and 4-5 smoke-treated mice were 
used per treatment group, and experiments were repeated to confirm results.  
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Figure 6.2: NOX2 drives cytokine production but not DAMP release after smoke inhalation. Sham 
samples are represented by open bars and smoke samples are represented by shaded bars. IL-10 
concentration (A) and MCP-1 concentration (B) were quantified in primary BALF samples 24h after 
inhalational injury or sham treatment in WT and CGD mice.  (C) dsDNA concentration was quantified in 
secondary BALF samples 24h after inhalational injury or sham treatment in WT or CGD mice.  (D) 
Hyaluronic acid concentration was quantified in primary BALF 96h after inhalational injury or sham 
treatment in WT or CGD mice. Data were analyzed by two-way ANOVA with Bonferroni post-test. 3-4 
sham and 4-5 smoke-treated mice were used per treatment group, and experiments were repeated to 
confirm results. 
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Figure 6.3: HIF1 stabilization attenuates smoke-dependent inflammation in WT but not CGD 
mice. Mice were treated with either DMOG (closed bars) or PBS vehicle control (open bars) immediately 
after and daily following inhalational injury.  Concentration of protein (A) and hyaluronic acid (B) were 
quantified in BALF at 24h following injury.  Concentraiton of CXCL1 (C) was quantified in BALF at 
96h following injury.  Total neutrophils (D) were measured as a percentage of live cells by flow 
cytometry and normalized to the total sample as determined by trypan blue staining. Data were analyzed 
by two-way ANOVA with Bonferroni post-test and significance indicated as * p < 0.05. 3-4 sham and 4-5 
smoke-treated mice were used per treatment group, and experiments were repeated to confirm results. 
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CHAPTER 7: CONCLUDING REMARKS  
In traumatic injury, what goes up must come down. 
 Survival after traumatic injury requires the body to create order form chaos, and the innate 
immune system is capable of acting as an asset or a hindrance in this process.  By their nature, injuries 
break barriers that normally hold microbes at bay, and the body is exposed to high concentrations of both 
damage-associated molecular patterns (DAMPs) from the injury and pathogen-associated molecular 
patterns (PAMPs) from microbes.  The immune system is designed to rapidly induce a pro-inflammatory 
response to neutralize microbes and then transition to an anti-inflammatory phenotype to promote wound 
closure and revascularization as PAMPs subside and DAMPs from the original injury and subsequent 
inflammation become prominent.  With severe injuries, especially burns, wound closure takes an 
exceptionally long time and the body must therefore juggle conflicting signals for weeks.  
 Until the early 20th century, severe injuries often caused mortality in the acute, pro-inflammatory 
phase due to inflammation that caused edema and disrupted function of critical organs, especially the 
heart and lungs. Novel resuscitation strategies designed to balance blood pressure and maintain 
circulation increased the fraction of patients who survived initial shock, and the next great obstacle was 
wound infections.  Wound care and cleaning, antimicrobials, and early excision and grafting have 
significantly attenuated this threat.  Today the greatest threat to patients in burn units is pulmonary 
infection occurring several days after hospitalization resulting from failure of immunological surveillance 
and protection in the lung.  Poor immune activity in the lung has been attributed to a predominantly anti-
inflammatory environment of a body trying to heal that suppresses antimicrobial innate immune function.  
Our objective is to investigate the immune mechanisms at play in the lung after trauma in order to tackle 
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this significant challenge to patient survival with a translational approach using both human samples and 
mouse models.  
 Here we report that the innate immune response to bacterial challenge is severely impaired after 
injury, and that despite significant pulmonary inflammation the lung remains a target for infection.  First, 
we demonstrated that in uninjured mice blood NO concentrations are elevated following pulmonary 
bacterial challenge and that this response is absent in injured mice.  We then showed that lack of NO 
response is not indicative of a muted innate immune response –in fact, burn injury leads to significant 
innate immune infiltration to the lung.  Burn injury leads to rapid accumulation of neutrophils in the 
pulmonary microvasculature, which may be driven by circulating DAMPs, since we show that 
intravenous DAMP administration amplified acute neutrophilia and prompted perturbation of the 
alveolar/capillary barrier. Moreover, we present evidence that neutrophil activity in situ is a significant 
determinant of their antimicrobial efficacy, since inhibiting activation of mTOR suppressed production of 
RONS production and TLR expression on neutrophils and was accompanied by failure to control 
Pseudomonas aeruginosa infection despite significant neutrophil recruitment.  
 To continue and expand our investigation of pulmonary damage and inflammation after traumatic 
injury, we developed a novel model of acute wood smoke exposure (Figure 7.1).  After validating the 
utility of the model system for studying phenotypes that are relevant to patient outcomes, we again 
observed that neutrophil recruitment is not protective against infection and may, in fact, promote 
immunopathology.  We arrived at this assessment through two sets of experiments.  First, we partially 
attenuated neutrophil trafficking to the lung after smoke inhalation but did not target neutrophil function, 
and we observed that this attenuated pathological inflammation without increasing susceptibility to 
bacterial challenge.  Next, to address the role of neutrophil function, we quantified the onset and 
resolution of inflammation in mice deficient for granulocyte NADPH oxidase, NOX2, compared to WT 
counterparts.  In the absence of neutrophil-derived ROS, tissue damage was not attenuated and 
inflammation was exaggerated, pointing to a failure to resolve inflammation.  
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iNOS and NOX2 drive inflammation in ALI 
Mechanistic findings in our smoke inhalation model reflect the current literature around ALI in a 
novel, translationally relevant context. iNOS expression has been noted in several animal studies of acute 
smoke inhalation (1-3).  In other models of ALI, iNOS plays a role in cytokine and chemokine production 
(4, 5).  We observed that iNOS was required for increases in IL-10, MCP1, and HA following injury.  
Our finding that clearance of PA01 was unchanged in iNOS-/- mice after smoke inhalation reflects 
previous data showing that iNOS activity is dispensable for P. aeruginosa (3).  
Similarly, our results about the impact of NOX2 activity on inflammation and resolution are in 
agreement with the literature.  NOX2 deficiency leads to unresolved inflammation following infection or 
injury that results in granulomas in patients, hence the disorder is named chronic granulomatous disease 
(CGD).  Mouse models of CGD suggest that neutrophil-derived ROS play an important role in activating 
signaling cascades that promote resolution and may therefore act as a natural fail-safe to promote 
resolution (6-9).  In other studies, the observation that pathology is more severe in NOX2 deficient mice 
led to the identification of downstream targets of NOX2 activity, such as Ref1, Nrf2, HIF1,  and NFB, 
that can be targeted in WT animals to promote efficient resolution (6, 9, 10).  
Targeting NOX2 signaling partners to resolve ALI 
 A role for neutrophil extracellular traps (NETs) in patients after burn and inhalational injuries has 
yet to be established; however, several mechanisms known to occur up- and down-stream of NETosis 
have been observed in patients and in our model of inhalational injury.  ROS generation and NOX2 
activity promote NETosis, which consist of DNA conjugated to enzymes and antimicrobial molecules that 
sequester and neutralize extracellular pathogens (7, 10, 11). Both apoptosis and NETosis begin with 
decondensation of the nuclear contents, after which point Caspase 3 cleavage and activation directs a cell 
toward apoptosis and failure to activate Caspase 3 predisposes a cell toward NETosis (10). Deficient 
NOX2 activity may polarize neutrophils toward NETosis rather than apoptosis, resulting in amplified 
inflammation (10). Cell-free dsDNA is elevated in serum and BALF from patients after traumatic injury, 
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which could be the result of NETosis (12, 13).  To confirm NETosis as a source of the DNA, future 
studies can determine whether DNA is conjugated to myeloperoxidase (MPO) or neutrophil elastase (7).  
We furthermore propose that it would be valuable to examine in vitro NETosis in neutrophils from blood 
and BALF of trauma patients, to determine whether they are predisposed to spontaneous NET formation, 
as has been observed in CGD patients (7).  
 Previous studies in CGD mice have demonstrated that NOX2-/- delays the onset of neutrophil 
apoptosis and decreases signals that promote clearance of apopototic neutrophils (6, 9, 10, 14).  
Harnessing these mechanisms in WT mice to improve neutrophil clearance, and the anti-inflammatory 
events that accompany normal resolution, may be an effective strategy to decrease lung damage in our 
mouse model and eventually in the patient population.   NFB activity delays neutrophil apoptosis, 
extending neutrophil lifespan and promoting further inflammation (9, 15). NOX2 activity suppresses 
NFB activity to effectively promote progression to apoptosis, and in NOX2-deficient neutrophils 
administration of hydrogen peroxide (H2O2) is sufficient to achieve the same effect (14).  A variety of 
approaches are available to determine the extent to which these mechanisms are at play in WT and CGD 
mice after smoke inhalation.  Several NFB inhibitors exist that promote neutrophil apoptosis; such 
treatment might offset the increased neutrophilia in CGD mice compared to WT, and may decrease 
inflammation after smoke inhalation in WT mice (14).  
During proper resolution, apoptotic neutrophils are cleared by macrophages, which phagocytose 
apoptotic neutrophils through a process called efferocytosis.  NOX2 activity in neutrophils promotes the 
translocation of a modified phosphatidylserine (lyso-PS) to the surface, which engages G2A on the 
surface of resident macrophages to induce efferocytosis (9) Efferocytosis triggers anti-inflammatory 
programs in macrophages, leading to decreased production of IL-6 and CXCL1/KC.  Neutrophils that are 
not efferocytosed after apoptosis progress to secondary necrosis, which promotes further inflammation by 
the release of intracellular contents.    
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Observational studies in humans and mechanistic studies in mice could determine the extent to 
which efferocytosis is occurring in the lung after smoke inhalation and whether promoting or inhibiting 
efferocytosis alters the long term inflammatory phenotype.  Ex vivo efferocytosis assays have been 
described, and it would also be useful to evaluate macrophage expression of G2A, which recognizes 
signals on the surface of apopototic cells, and CD206, which is highly expressed on efferocytotic 
macrophages (16). These readouts can be measured in WT and CGD mice and in cells derived from 
BALF of patients diagnosed with inhalational injury.  To assess the utility of promoting efferocytosis in 
promoting healthy resolution after inhalational injury, mice can be treated with antibodies that neutralize 
G2A, which block efferocytosis.  If our hypothesis is correct and efferocytosis is critical for removing 
neutrophils and promoting anti-inflammatory cytokine production in tissue-resident macrophages, then 
G2A blockade should increase the number of inflammatory cells and DAMPs present in the BALF after 
smoke inhalation.   
Where there’s smoke, there’s fire. 
Given the established utility of our inhalational injury model for mimicking patient phenotypes 
after smoke inhalation, an important application for this model is to test the role of injury-related 
variables.  Combined burn and smoke inhalational injuries lead to increased mortality, and studies are 
currently underway in our laboratory to examine the compounded effect of these two injuries.  
Furthermore, because clinical outcomes are driven by comorbidities including age, BMI, and smoker 
status, these variables should be incorporated into future studies of acute smoke inhalation in mice.  
Finally, the severity of inhalational injuries depends largely on the type of structure in which smoke was 
generated.  Although this may have to do with ventilation in the structure, we propose that this distinction 
is also driven by the chemical makeup of the smoke, which can be more clearly elucidated using our 
experimental setup.   Any of these studies, if successful, would have a significant positive impact on 
patient outcomes.   
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FIGURES 
 
Figure 7.1: ALI following wood smoke inhalation. Like other models of ALI, wood smoke inhalation 
results in protein buildup, immune cells (neutrophils), and cytokines (MCP1, IL-10) in BALF following 
smoke inhalation, as well as congestion of microvasculature.  We have demonstrated that neutrophilia is 
largely driven by CXCL1 accumulation in the BALF and that IL-10 is derived from macrophages.  Future 
studies will determine the cellular source of CXCL1 as well as the molecular mechanisms that cause 
increases in dsDNA and HA following smoke inhalation.  Abbreviations: acute lung injury (ALI); 
broncho-alveolar lavage fluid (BALF); double-stranded deoxyribonucleic acid (dsDNA); chemokine (c-x-
c motif) ligand 1 (CXCL1); hyaluronic acid (HA); interleukin 10 (IL-10); monocyte chemotactic protein 1 
(MCP1); red blood cell (RBC).  
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